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INTRODUCTION 
Elevation of plasma-triglyceride and cholesterol levels appears to 
be related independently to atherosclerotic disease (Carlson and Bottiger, 
1981). Both abnormalities can be found in diabetes, but it has become 
increasingly evident that hypertriglyceridemia is much more common than 
hypercholesterolemia in diabetic subjects with atherosclerosis (Nikkilâ, 
1973; Reckless et al., 1978). 
Effects of dietary fat composition on blood lipid metabolism is still 
not fully understood. In general, a diet rich in polyunsaturated fatty 
acids appears to be associated with lower lipid levels, including tri­
glyceride and cholesterol levels, than one containing larger quantities 
of saturated fatty acids and/or cholesterol (Goodnight et al., 1982). 
Since apoproteins have structural and regulatory functions in lipid 
metabolism, they cannot be overlooked when studying effects of dietary 
fat on plasma lipid levels. 
The main objective of the present study was to compare dietary and 
insulin-deficiency types of hyperlipidemia by investigating plasma glu­
cose, insulin and lipoprotein lipids and proteins in adult normal and 
streptozotocin-induced diabetic male breeder rats. It is hypothesized 
that excess intake of high-saturated fat diets may contribute to a 
metabolic pattern resembling that of a diabetic state. 
Adult male breeder rats were used as an animal model, since they 
have been shown to have higher plasma-triglyceride and cholesterol levels 
than virgin male rats of the same age (Wexler, 1976). One might speculate 
that changes in lipid metabolism due to diet manipulations will be more 
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severe in breeder rats than virgin rats. 
In order to ensure that consumption of a high-saturated fat diet is 
responsible for changes in blood lipid metabolism, which resemble those 
in a diabetic state, effects of a high-polyunsaturated fat diet or a 
low-fat purified diet upon blood lipid metabolism were also investigated. 
To accentuate effect of type of fat, some normal rats were switched 
directly from a high-saturated to a high-polyunsaturated fat diet. A 
reverse switch (high-polyunsaturated to high-saturated fat diets) was 
also done. 
Streptozotocin-induced diabetic rats were used to compare animals 
fed the various experimental diets with animals known to be metabolically 
different through chemical induction of diabetes. 
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REVIEW OF LITERATURE 
Introduction 
The scientific literature covering areas of lipoprotein and apo­
protein metabolism is enormous and many detailed review articles have 
been published (Alaupovic, 1980; Brewer, Jr., 1981; Eisenberg and Levy, 
1975; Getz and Hay, 1979; Schaefer et al. , 1978b). This review of litera­
ture will be restricted primarily to the major lipoprotein classes (very 
low density lipoprotein (VLDL), low density lipoprotein (LDL) and high 
density lipoprotein (HDL)) including the major apoproteins (A, B, C, E) 
associated with them. Human and rat plasma have been the major sources 
for investigation of lipoprotein and apoprotein metabolism, and most of 
the following discussion will rely on information using research from 
humans and rats. Species differences have to be considered when com­
paring results of different investigations. Although quantitative dif­
ferences in some aspects of lipoprotein and apoprotein biosynthesis and 
catabolism exist between the two species (Havel, 1980), most of the 
metabolic processes are rather similar (Chapman, 1980; Eisenberg and 
Rachmilewitz, 1975). For example, human plasma contains much more lipo­
protein of all classes than rat plasma; there is twice as much HDL, 20-25 
times as much LDL and four times as much VLDL in human plasma as there 
is in that of the rat (Getz and Hay, 1979). Rat plasma, on the other 
hand, contains more apo-E particularly in HDL than does human plasma 
(Havel, 1980). 
The following literature review will include studies on normal 
lipoprotein and apoprotein metabolism, defects of lipoprotein and apo-
2b 
protein metabolism during a diabetic state, dietary effects (amount and 
degree of saturation of dietary fat) on lipoprotein and apoprotein 
metabolism, and effects of diet and diabetes on plasma glucose and in­
sulin levels. 
Normal Lipoprotein Metabolism 
Introduction 
Transport of lipids in plasma, an aqueous medium, is accomplished 
by water-soluble macromolecular complexes called lipoproteins. The 
nomenclature for lipoproteins (Alaupovic et al., 1972) was based on their 
ultracentrifugal separation at characteristic densities determined by 
the relative proportions of lipid and protein in the particles (Lindgren, 
1980). The lipoprotein classes are customarily designated as chylo­
microns, VLDL, LDL and HDL. These classes, however, do not constitute 
absolute categories since within each class, there is heterogeneity with 
respect to size, lipid and protein composition (Getz and Hay, 1979). 
Basically, all lipoproteins share the same structural profile: they 
consist of a hydrophobic core, mainly triglyceride and cholesteryl ester, 
surrounded by an amphipathic surface layer of phospholipid, cholesterol 
and specific proteins called apoproteins (Brewer, Jr., 1981). Chylo­
microns and VLDL are primarily composed of triglyceride; LDL is the major 
cholesterol carrying vehicle, and HDL molecules have the highest protein 
and phospholipid levels compared to all other lipoproteins. 
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Chylomicrons and very low density lipoprotein 
Chylomicrons and VLDL share many structural features and are, there­
fore, discussed together. Chylomicrons and VLDL transport chiefly 
exogenous and endogenous triglyceride from the intestine and liver, 
respectively, for utilization or storage in peripheral tissues (Getz and 
Hay, 1979). Both of these processes are markedly influenced by changes 
in hormones, such as insulin and glucagon levels (Getz and Hay, 1979; 
Nikkila, 1973). Chylomicrons are synthesized in the intestinal mucosa 
where they combine with apo-B and enter the blood stream via the thoracic 
duct. Instead of dietary fat, precursors for VLDL-triglyceride synthesis 
are dietary carbohydrates, circulating fatty acids and other short-
carbon-chain fractions. The major site of VLDL synthesis is the liver, 
where the lipids are combined with apo-B and the VLDL then released into 
the bloodstream (Levy, 1981). 
Triglyceride-rich particles, intestinal chylomicrons and hepatic 
as well as intestinal VLDL are hydrolyzed by lipoprotein lipase at 
capillary surfaces of peripheral tissues such as adipose and muscle cells 
(Nilsson-Ehle et al., 1980). One of the apoproteins, HDL-derived apo-CII, 
is needed for optimal activity of lipoprotein lipase (Nilsson-Ehle et al., 
1980). After initial hydrolysis, further modification of the particles 
produced can also occur by a triglyceride lipase originating in the 
liver (Nilsson-Ehle et al., 1980). Progressive delipidation of VLDL and 
chylomicrons leads to the formation of lipoproteins of intermediate 
density (IDL) and chylomicron remnants, respectively. IDL finally is 
degraded to LDL (Eisenberg and Rachmilewitz, 1975). 
To determine the effect of activation of lipoprotein lipase on the 
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metabolism of 124l-labeled VLDL, Eisenberg and Rachmilewitz (1975) in-
125 jected heparin into rats which were preinjected with I-labeled VLDL. 
The investigators determined that there was only one single mechanism of 
formation of IDL and LDL in humans and rats either in vivo or in vitro. 
Eisenberg and Rachmilewitz (1975) also found that the lipid and apoprotein 
composition of IDL more closely resembled a "triglyceride-rich" LDL 
rather than a "triglyceride-poor" VLDL. Thus, the IDL represents an 
unstable lipoprotein form that is either removed from the circulation by 
the liver (primarily in rat (Steinberg, 1979)) or converted into LDL 
(primarily in human (Getz and Hay, 1979)). Bierman et al. (1973) re­
ported that IDL was catabolized more efficiently than VLDL by arterial 
smooth muscle cells in tissue culture. In the rat (Chapman, 1980), 
triglyceride concentration was higher in VLDL and lower in LDL compared 
to IDL. 
Low density lipoprotein 
The catabolism of LDL occurs in peripheral cells (e.g., smooth 
muscle cells, fibroblasts, endothelial cells) and in the liver (Brewer, 
Jr., 1981). A high affinity receptor process in peripheral cells has 
been elucidated by Goldstein and Brown (1977). The binding of LDL to 
these receptors and subsequent internalization and degradation of LDL 
has a regulatory effect on cellular cholesterol metabolism. In addition 
to LDL (which contain primarily apo-B), certain HDL (which contain rela­
tively large amounts of apo-E) have been shown to interact with receptors 
on peripheral cells and, thus, influence intracellular regulation of 
cholesterol metabolism (Mahley, 1981). 
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High density lipoprotein 
HDL has been called a "polydisperse collection of lipoprotein 
particles" (Brewer, Jr., 1981), and functions and metabolic pathways of 
the HDL system are therefore very intricate. The heterogeneity of HDL 
has been demonstrated primarily by techniques including hydrated 
densities (HDL^, HDL^ and HDL^) and apoprotein composition (Brewer, Jr., 
1981; Getz and Hay, 1979). Nascent HDL particles are released by the 
liver and intestine into the plasma where they are rapidly transformed 
into spherical HDL particles by plasma components (Getz and Hay, 1979). 
Intravascular hydrolysis of triglyceride-rich lipoproteins (chylo­
microns and VLDL) from the intestine and liver results in the transfer of 
lipids and apoproteins (except apo-B) to HDL (Alaupovic, 1981; Getz and 
Hay, 1979). As a result, lipids such as cholesterol and phospholipids 
are transferred to HDL where the enzyme leci thin-choies ter ol-acy1-
transferase (LCAT) catalyzes the transfer of fatty acids found in the 
P-position of phospholipids to free cholesterol. The cholesteryl 
ester produced can be transferred back to LDL and VLDL. Also, net 
transfer of cholesteryl ester from human or rabbit LDL to VLDL and a 
net transfer of triglyceride from VLDL to LDL has been reported in vitro 
(Barter et al., 1980). 
Animal studies indicate that intestine, liver and kidney are major 
sites of SDL removal (Getz and Hay, 1979). KDL has been postulated to 
transport cholesterol from various peripheral tissues to the liver for 
final elimination from the organism (Glomset, 1979). Mahley (1981) 
showed in the canine that high cholesterol feeding resulted in the pro­
duction of a particle he called HDL^ from typical HDL which became en­
6 
riched in cholesterol and apo-E. Mahley (1981) suggested then that the 
function of HDL^ would be to transport cholesterol from peripheral tissues 
to the liver for excretion, with hepatic recognition of EDL^ mediated 
by apo-E. 
Normal Apoprotein Metabolism 
Introduction 
In addition to their role in maintaining lipoprotein structure, apo­
proteins play important regulatory roles by serving as cofactors for 
enzymes in lipid metabolism. For example, apo-Al and apo-CII are neces­
sary cofactors for LCAT and lipoprotein lipase, respectively (Nilsson-
Ehle et al., 1980) ; apo-B and apo-E function as binding ligands for cellular 
receptors (Mahley, 1981). Recently discovered apoproteins such as apo-D 
and apo-H are thought to function as cholesterol ester exchange protein 
and cofactor for lipoprotein lipase, respectively (Brewer, Jr., 1981). 
Metabolism of apo-B, E, C, and A will be discussed. 
Apo-B 
Apo-B which is synthesized in both the liver and intestine enters 
the circulation with either chylomicrons or VLDL (Schaefer et al,, 1978b). 
Apo-B appears to be necessary for formation and secretion of triglyceride-
rich particles (Getz and Hay, 1979), because without apo-B, triglyceride 
is not transported out of the liver and into the blood stream (Levy, 1981). 
Sparks and Marsh (1981) recently isolated two apo-B components (MW 300,000D 
and 80,GOOD) and reported preferential binding and catabollsm of 
triglyceride-rich lipoproteins enriched in apo-B with MW of 80,000D. 
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In contrast to other apoproteins, physical properties of apo-B are very 
similar to membrane proteins which are not readily soluble in aqueous 
solutions (Schaefer et al., 1978b). 
There exists a direct precursor-product relationship between apo-B 
in VLDL and LDL, respectively (Eisenberg and Rachmilewitz, 1975; Getz 
and Hay, 1979). Brewer, Jr. (1981) discussed two types of interactions 
between apoproteins and plasma lipoproteins. In the "quasi-irreversible" 
apoprotein-lipoprotein interaction, the same apoprotein remains attached 
to the same lipoprotein particle during metabolism. Chylomicron-apo-B 
and liver VLDL-apo-B are examples of the "quasi-irreversible" mechanism. 
Thus, apo-B remains associated with the VLDL-IDL-LDL delipidation cascade. 
On the other hand, "reversible" apoprotein-lipoprotein interactions are 
exemplified by apoproteins A, C and E (Brewer, Jr., 1981). These apo­
proteins are able to exchange between lipoprotein particles and, there­
fore, cannot be used as markers for the metabolism of particular 
lipoproteins. The clearance of apo-B from the circulation is thus 
thought to occur primarily in the form of LDL particles (Schaefer et al,. 
1978b). 
The catabolism of LDL which occurs in peripheral cells is initiated 
by apo-B affinity receptors (Goldstein and Brown, 1977). Mahley and 
Innerarity (1977) also showed that both apo-B of human LDL and apo-E of 
canine HDL^ can interact with the same receptor sites in human fibro­
blasts. Trace amounts of apo-B can be found in human HDL^ (Getz and Hay, 
1979). Swaney et al. (1977), however, did not find apo-B in rat HDL. 
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Apo-E 
Apo-E is found in VLDL, LDL and HDL, and the percent distribution 
is species dependent (Chapman, 1980; Schaefer et al,, 1978b). Apo-E can 
be synthesized in the liver and intestine (Schaefer et al., 1978b) and the 
major catabolic site of apo-E appears to be the liver (Havel, 1980). 
Apo-E apparently enters the circulation from the liver with nascant HDL 
particles and is then transferred to VLDL during cholesterol ester forma­
tion (Schaefer et al., 1978b) . Norum et al. (1975) reported that apo-E 
was transferred from HDL to VLDL when the plasma from LCAT deficient 
patients was incubated with an LCAT enzyme preparation. Generally, the 
concentration of apo-E is considerably higher in rats than humans (Havel, 
1980). Lipolytic breakdown of VLDL causes a net mass transfer of apo-E 
from VLDL to HDL particles (Alaupovic, 1981). Eisenberg and Levy (1975) and 
Schaefer et al.(1978b), however, reported that apo-E may contribute 
significantly to the apoprotein content of intermediate lipoproteins. 
Reports on a possible role of apo-E in the metabolism of triglyceride-
rich VLDL or IDL particles are contradictory. Apo-E has been shown to 
strongly inhibit apo-CII activated lipoprotein lipase (Ekman and Nilsson-
Ehle, 1975; Ganesan et al., 1976). On the other hand, Yamada and Murase 
(1980) reported that apo-E significantly activated lipoprotein lipase, 
while activity of this enzyme was inhibited by apo-E antibody. Despite 
Mahley's claim of HDL^ (rich in apo-E) being "anti-atherogenic" (Hahley, 
1981), no association has been found between levels of plasma apo-E and 
angiographically documented coronary artery disease (Miller et al., 1981). 
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Apo-C 
As with apo-E, newly synthesized triglyceride-rich liver and intestine 
lipoproteins are relatively devoid of apo-C, which is synthesized in the 
liver (Schaefar et al., 1978b). However, both apo-E and apo-C rapidly 
associate with newly synthesized lipoprotein particles in the circulatory 
system (Brewer, Jr., 1981). Apo-C can also exchange between VLDL and 
HDL and is, therefore, an example of "reversible" apoprotein-lipoprotein 
particle interactions (Brewer, Jr., 1981). Several investigators 
(Alaupovic, 1981; Eisenberg and Rachmilewitz, 1975) have reported that 
the content of apo-C in VLDL was related to the content of triglycerides 
in VLDL and that it was independent of all other lipoproteins, especially 
apo-B. The rate of release of apo-C-containing lipoprotein particles 
from VLDL to HDL (particularly HDLg) during lipolysis has been suggested 
to reflect the state of triglyceride metabolism (Alaupovic, 1981). 
Berman et al. (1981) found that calculated rate constants for transfer 
of triglyceride between VLDL and HDL were similar compared to those for 
apc-C exchanges. Thus, apo-C could be a marker for triglyceride clearance 
during lipolysis of triglyceride-rich particles (Mao and Kottke, 1981). 
Apo-C metabolism has been suggested to be independent of apo-B and apo-A 
since apo-C is found in the plasma of patients with either abetalipo-
proteinemia (absence of circulating apo-B) (Gotto, Jr. et al., 1971) or 
Tangier disease (apo-A and HDL deficiency) (Assman et al., 1977). 
The C apoproteins, CI, CXI and CIII, have similar molecular weights 
but different functions related to lipid metabolism. Apo-CI has been 
reported to activate LCAT (esterification of plasma cholesterol) (Jack­
son et al., 1976) and both to inhibit (Ekman and Nils son-Ehle, 1975) and 
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to activate lipoprotein lipase (Ganesan et al., 1975). Apo-CII, which 
is provided primarily by HDL, is essential for intravascular lipolysis 
as an activator of lipoprotein lipase (Nilsson-Ehle et al., 1980). 
Apo-CIII has been shown to inhibit the activation of lipoprotein lipase 
(Ganesan et al., 1976; Saudek and Eder, 1979). The inhibitory effect of 
apo-CIII, however, could be reversed by increases in apo-CII or tri­
glyceride concentrations (Ganesan et al., 1976). 
Apo-A 
In man, apo-AI and apo-AII are the major apoproteins of HDL (Schaefer 
et al., 1978b). Apo-AII, however, is only a minor component of rat HDL 
(Swaney et al., 1977). Trace amounts of apo-A can also be detected in 
other lipoprotein fractions (Curry et al., 1976). Rat VLDL and HDL also 
contain apo-AIV (Swaney et al., 1977) which recently has been discovered 
in human plasma (Beisiegel and Utermann, 1979). Apo-A is largely derived 
from the intestine (Zilversmit, 1979) but also from the liver (Schaefer 
etal., 1978b). Catabolic sites of apo-A are liver and kidney lysosomes 
(Schaefer et al., 1978b). Some reports indicate that apo-A, like apo-B, 
E and C, can move freely from one lipoprotein to another (Brewer, Jr., 
1981; Zilversmit, 1979). Alaupovic (1981), however, reported that apo-C 
and apo-E but not apo-A aid apo-B could exchange between VLDL and HDL. 
Apo-A apoproteins are thought not to be involved in the transport of 
lipids out into the plasma but rather of lipid clearance from the plasma 
(Levy, 1981). 
Apo-AI is the major activator of LCAT, and plasma levels of apo-AI 
and apo-AII are low in patients with LCAT deficiency (Getz and Hay, 1979). 
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In the rat, chylomicron-and VLDL-choiesteryl esters are primarily syn­
thesized in cells producing these lipoproteins but almost all of the HDL-
and also LDL-cholesteryl ester is probably derived from the action of 
LCAT upon HDL (Havel, 1980). Both apo-AI and apo-AII also have been 
shown to inhibit the activation of human adipose tissue lipoprotein 
lipase (Ekman and Nilsson-Ehle, 1975). 
Recently, much interest has been focused upon apo-AI, in addition 
to HDL-cholesterol levels, in relation to coronary artery disease and its 
risk factors. Fager et al. (1980) found lower levels of apo-AI in sur­
vivors of myocardial infarction compared to a control group. Maciejko 
et al. (1982) reported that, out of 84 male patients with severe coronary 
artery disease (diagnosed by coronary angiography), 34 had normal levels 
of HDL cholesterol while all had abnormally low levels of apo-AI. 
Maciejko et al. (1982) then suggested that apo-AI levels may be a better 
indicator of possible coronary artery disease than HDL-cholesterol levels. 
On the other hand. Miller et al. (1981) found no association between 
angiographically defined coronary artery disease and apo-AI levels, but 
HDLg levels were lower in patients with the disease than in the control 
group. 
Defects of Lipoprotein and Apoprotein Metabolism during Diabetes 
Introduction 
Elevations of plasma triglyceride and cholesterol levels appear to 
be related independently to atherosclerotic vascular disease (Carlson 
and Bo'ttiger, 1981). Both abnormalities, however, can be found in 
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diabetes, but it has become increasingly evident that hypertriglyceridemia 
is much more common than hypercholesterolemia in diabetic subjects with 
atherosclerosis (tlikkila, 1973; Prager et al., 1980; Reckless et al., 
1978). Some disagreement exists in the literature about alterations in 
individual lipoprotein and apoprotein patterns in diabetes. Interpreta­
tions can be difficult because of the many factors in diabetes that in­
fluence blood lipid levels, including insulin levels, obesity, age, sex, 
the type of diabetes and the genetic heritage of the diabetic patients 
under study (Saudek and Eder, 1979). One of the characteristics of un­
treated or poorly controlled juvenile-type diabetes (type I or insulin-
dependent diabetes), as well as experimental diabetes induced, for example, 
by streptozotocin, is insulin deficiency. Hyperinsulinism, on the other 
hand, is a characteristic feature of many obese subjects with adult-onset 
diabetes (or type II or noninsulin-dependent diabetes) (Saudek and Eder, 
1979). In general, the lack of insulin in insulin-dependent diabetes 
and the obesity and hyperinsulinemia in noninsulin-dependent diabetes 
could each affect factors regulating hepatic input of lipoproteins into 
plasma (such as hepatic lipogenesis, triglyceride and protein synthesis) 
and factors contributing to the catabolism of lipoproteins (such as 
lipoprotein lipase activity) (Nikkila, 1973). 
Lipoprotein-triglycerides 
Diabetes is usually (Nikkila, 1973) but not always (Taylor et al., 
1981) accompanied by hypertriglyceridemia. Theoretically, the rise in 
plasma triglyceride levels could result from increased lipoprotein pro­
duction or from decreased removal of circulating lipoproteins. 
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Enhanced lipolysis in adipose tissue has been suggested to contribute 
to hypertriglyceridemia by providing increased amounts of precursors 
(fatty acids) for triglyceride synthesis in the liver (Mancini et al., 
1980). Plasma-and VLDL-triglyceride levels decreased in both obese 
nondiabetic and obese noninsulin-dependent diabetic Pima Indians after 
several months of consumption of a 500 calorie diet (Howard et al., 
1979). Many noninsulin-dependent diabetic patients are obese, and 
Clefsky et al. (1974) proposed that hypertriglyceridemia may be the 
consequence of insulin resistance, which in turn leads sequentially to 
hyperinsulinemia, increased VLDL production and, hence, elevated tri­
glyceride levels. Brunzell et al. (1979) have found no evidence for an 
increase in triglyceride production in untreated diabetes. In addition, 
perfused livers of diabetic rats secreted less VLDL-triglyceride and in­
corporated less amino acid into secreted VLDL-protein (Getz and Hay, 
1979). Bar-On et al. (1976a), on the other hand, reported a fivefold in­
crease in VLDL-protein in diabetic compared to control rats. Thus, in 
addition to increased synthesis, impaired catabolism or removal of lipo­
proteins could lead to diabetic hyperlipidemia. 
A defect in lipoprotein removal has been reported in streptozotocin-
induced diabetic rats (Chen et al., 1979; Reaven and Reaven, 1974; van Toi, 
1977) and untreated diabetic humans (Brunzell et al., 1979). Impaired 
extrahepatic lipoprotein lipase (Brunzell et al., 1979; Getz and Hay, 
1979; Pykâlisto et al., 1975) and not hepatic triglyceride lipase (Nikkila 
et al., 1977) may be, in part, responsible for the diabetic hyperlipidemia. 
Tritiated VLDL-palmitate was removed more slowly from the circulation 
of diabetic compared to normal rats (van Toi, 1977). Insulin therapy 
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increased lipoprotein lipase activity (Taskinen and Nikkila, 1979) and 
resulted in rapid decreases in chylomicrons and VLDL in patients with 
diabetic ketoacidosis (Weidman et al., 1982). 
Schonfeld et al. (1974) and Mancini et al. (1980) reported the ac­
cumulation of triglyceride-rich LDL in diabetic patients. Elevated LDL-
triglyceride and HDL-triglyceride levels were found in insulin-dependent 
diabetic patients with electrocardiographic evidence of myocardial in­
farction (Aro et al., 1981). The elevated triglyceride levels in the 
LDL fraction (d = 1.006 to 1.063 g/ml) have been related to a relative 
increase in IDL and accumulation of remnant particles of similar density 
(Mancini et al., 1980). 
Lipoprotein-cholesterol 
Reports about lipoprotein cholesterol levels in diabetes have not 
been consistent. Elevation in total plasma cholesterol has been found in 
streptozotocin-induced diabetic rats (Deutsch et al., 1980) and both in 
insulin-dependent (Taskinen and Nikkila, 1979; Mattock et al., 1979) and 
noninsulin-dependent diabetic humans (Mattock et al., 1979). On the 
other hand, Alaupovic et al. (1982) and Aro et al. (1981) reported no 
change in total cholesterol in noninsulin-dependent diabetic patients 
compared to control groups. Several investigators have reported increased 
levels of VLDL-cholesterol in insulin-dependent (Lopes-Virella et al., 
1981; Taskinen and Nikkila, 1979) and noninsulin-dependent diabetic 
humans (Alaupovic et al., 1982; Aro et al., 1981). 
Elevated levels of LDL-cholesterol have been shown both in insulin-
dependent (Loves-Virella et al., 1981; Reckless et al., 1978) and 
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noninsulin-dependent (Taskinen and Nikkila, 1979) diabetic patients but 
vascular disease was only associated with insulin-dependent (Reckless 
et al., 1978) but not noninsulin-dependent diabetic patients (Aro et al., 
1981; Reckless et al., 1978). No changes in LDL-cholesterol levels in 
noninsulin-dependent diabetic patients were found by Alaupovic et al. 
(1982) and Aro et al. (1981). A decrease in LDL cholesterol levels has 
been reported in the diabetic rat (van Toi, 1977). Increase in cholesterol 
synthesis or decrease in removal could lead to increased cholesterol levels 
in both VLDL and LDL. Nakayama and Nakagawa (1977) and Saudek and Eder 
(1979) found increased HMG-CoA reductase activity in the intestine of 
rats with streptozotocin-induced diabetes. Impaired lipoprotein lipase 
activity in diabetic populations has been mentioned earlier. 
In general, both insulin-dependent (Lopes-Virella et al., 1981; 
Taskinen and Nikkila, 1979) and noninsulin-dependent diabetic subjects 
(Aro et al., 1981; Mattock et al., 1979; Taylor et al., 1981) have de­
creased HDL-cholesterol levels. Bar-On et al. (1976b), however, found un­
changed cholesterol content in HDL of streptozotocin-induced diabetic 
rats, and Mattock et al. (1979) reported elevated HDL-cholesterol levels 
in insulin-dependent patients. Insulin therapy tended to increase HDL-
cholesterol levels in diabetic patients (Prager et al., 1980; Weidman 
et al,, 1982), but Taskinen and Nikkila (1979) did not find an increase 
in HDL cholesterol after treating insulin-dependent patients for two weeks. 
Most literature results, therefore, suggest an increase in VLDL- and LDL-
and a decrease in HDL cholesterol levels in diabetic compared to normal 
populations. Thus, a mild increase in total cholesterol in diabetes could 
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be secondary to an increase in VLDL- and/or LDL-cholesterol (Saudek and 
Eder, 1979). 
Lipoprotein-protein 
An elevation of total protein in lipoprotein fractions of diabetic 
rats has been reported by Bar-On et al. (1976b). On the other hand, in­
corporation of radioactive amino acids into the major lipoproteins was 
depressed in the perfused liver of alloxan-induced diabetic rats (Getz 
and Hay, 1979). In general, individual apoproteins appear to be affected 
by a diabetic state (Saudek and Eder, 1979), but findings reported in 
the literature are rather inconsistent. 
Apo-B 
Plasma-apo-B levels were higher in both insulin-dependent (Alaupovic, 
1980; Schonfeld et al., 1974) and noninsulin-dependent diabetic (Schonfeld 
et al., 1974) compared to control subjects. Bar-On et al. (1976b) found 
an increase in plasma apo-B by 86% in streptozotocin-induced diabetic com­
pared to control rats. However, Alaupovic et al. (1982) reportednonnai levels 
in noninsulin-dependent diabetic subjects. Similar results were obtained 
by Prager et al. (1980) who investigated apo-B levels both in insulin­
dependent and noninsulin-dependent patients. Apo-B levels tended to be 
higher in children with diabetes but were statistically not different 
from those of healthy controls (Tuvemo et al., 1981). Plasma-apo-B 
levels decreased with insulin treatment due to a decrease in VLDL-apo-B 
but not LDL- or IDL-apo-B levels (Weidman et al., 1982). 
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Apo-E 
Increased plasma-apo-E levels were found in insulin-dependent 
(Alaupovic, 1980), but noninsulin-dependent diabetic patients had normal 
apo-E levels (Alaupovic et al,, 1982). A significant decrease in apo-E 
levels was observed in the diabetic rat (Bar-On et al., 1976b) due to , 
almost absence of apo-E in HDL of diabetic compared to control rats. 
Deutsch et al. (1980) also found a major decrease in HDL-apo-E levels in 
diabetic rats. 
Apo-C 
An increase in plasma-apo-C levels has been observed in diabetic 
rats (Bar-On et al., 1976b) and insulin-dependent diabetic patients 
(Alaupovic, 1980). The apo-C changes (diabetic vs. control) in the rat 
(Bar-On et al., 1976b) appeared to be similar in VLDL and HDL. Alaupovic 
(1980) also reported an increase in apo-CIII in noninsulin-dependent 
diabetic patients compared to a control population. 
Aps-A 
Prager et al. (1980) found decreased plasma-apo-AI and apo-AlI 
levels in both insulin-dependent and noninsulin-dependent diabetic 
patients compared to a control population. Similar results have been 
reported by Alaupovic et al. (1982). On the other hand, Tuvemo et al. 
(1981) reported significantly higher levels of apo-Al in diabetic com­
pared to normal children. Apo-All levels also tended to be higher in 
the diabetic children. Plasma apo-AI levels were not lower in noninsulin-
dependent diabetic patients with normal plasma triglyceride levels com­
pared to normal subjects (Taylor et al., 1981). Bar-On et al. (1976b) 
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found apo-AIV in diabetic rat VLDL. Apo-AIV which is normally present 
in rat HDL could not be detected in HDL of diabetic rats (Bar-On et al., 
1976b). Inhuman diabetic ketoacidosis (Weidman et al., 1982), apo-Al 
levels were normal, decreased upon insulin treatment initially and 
reached basal levels again 24 hours after treatment. 
The various effects of the several forms of diabetes in rats and 
humans upon lipoproteins are summarized in Table 1. 
Dietary Fat Effects on Lipoprotein and Apoprotein Metabolism 
Introduction 
In the United States, about 42% of the energy in the diet comes from 
fat (Rizek, 1981). About 15% of dietary energy comes from saturated 
fatty acids and about 6% from polyunsaturated fatty acids (Hershcopf 
et al., 1982). Since diets high in saturated fat and/or cholesterol 
have been shown to be atherogenic (Kris-Etherton and Cooper, 1980), much 
research has been focused on how the extent of changes of fatty acid 
composition of dietary fats might affect plasma lipid levels. In 
general, a diet rich in polyunsaturated fatty acids appears to be as­
sociated with lower lipid levels, including triglyceride and cholesterol 
levels, than one containing larger quantities of saturated fatty acids 
and/or cholesterol (Goodnight et al., 1982). 
Lipoprotein-triglycerides 
Stimulation of triglyceride output by the perfused liver has been 
shown to increase with fatty acid chain length, at least up to 18 carbon 
atoms (Kohout et al., 1971). Plasma triglyceride levels were higher 
Table 1. Sumaary of recent reports of defects of apoprotein metabo­
lism during diabetes 
Apoprotein 
Rat 
(s trep tozotocin-
induced diabetes) Reference 
apo-B ^(plasma) Bar-On et al., 1976b 
apo-E 
apo-C 
apo-A 
I (plasma) 
\ (HDL) 
I (HDL) 
t (plasma) 
Bar-On et al., 1976b 
Bar-On et al., 1976b 
Deutsch et al., 1980 
Bar-On et al., 1976b 
^NS = not statistically significant. 
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Human 
Insulin-dependent 
Noninsulin-dependent 
(ID) 
(NID) Reference 
^(plasma) 
NS^ (plasma) 
NS (plasma) 
NS (plasma) 
^(plasma) 
NS (plasma) 
ID 
NID 
NID 
ID 
NID 
ID 
Alaupovic, 1980 
Schonfeld et al., 1974 
Alaupovic, et al., 1982 
Prager et al., 1980 
Prager et al., 1980 
Schonfeld et al., 1974 
Tuvemo et al., 1981 
^(plasma) 
NS (plasma) 
ID 
NID 
Alaupovic, 1980 
Alaupovic et al., 1982 
f(plasma) ID Alaupovic, 1980 
t(plasma) 
^(plasma) 
^(plasma) 
^(plasma) 
^(plasma) 
ID 
NID 
ID 
NID 
ID 
Alaupovic et al., 1982 
Alaupovic et al., 1982 
Prager et al., 1980 
Prager et al., 1980 
Tuvemo et al., 1981 
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in rats fed a diet high in beef tallow compared to rats fed a high-corn oil 
diet (Koh and Chi, 1981). A marked increase in VLDL-triglyceride was ob­
served in human subjects who consumed high-coconut oil compared to high-
corn oil diets (Fisher et al., 1981). On the other hand, plasma-tri­
glyceride levels in rhesus monkeys (Ershow et al., 1981) were not al­
tered by either high-coconut oil or corn oil diets (31% of energy each). 
Turner et al. (1981) also found no change in plasma-triglyceride levels 
in humans fed diets with P/S ratios of 8.0 or 0.2. 
Polyunsaturated fat feeding caused a decrease in plasma-triglyceride 
levels in humans (Shepherd et al., 1978, 1980) and in both normal and 
diabetic monkeys (Howard, Jr., 1979). Chait et al. (1974) attributed a 
decrease in plasma-triglyceride levels during polyunsaturated fat feeding 
primarily to a decrease in VLDL-triglyceride levels. In chronically 
insulin deficient rats, however, hypertriglyceridemia was accentuated by 
consumption of a high-fat diet (30% of energy from corn oil) compared to 
a high-carbohydrate diet (Reaven and Reaven, 1974). High-carbohydrate 
diets, at least on a short-term basis, have been shown to induce 
elevated levels of VLDL-triglyceride (Brussaard et al., 1980; Falko et al., 
1980; Saudek and Eder, 1979). 
Feeding a diet high in coconut oil rather than corn oil to humans 
resulted in an increase in LDL-triglyceride levels (Fisher et al., 
1981). Similar diets were fed to monkeys (Ershow et al., 1981), but 
no changes in LDL-triglyceride levels were observed. In another study, 
however, high polyunsaturated fat (P/S ratio of 2.4) compared to high 
saturated fat (P/S ratio of 0.2) diets had no significant effect on LDL-
triglyceride levels (Chait et al., 1974). Brussaard et al. (1980) 
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reported that a diet low in fat (fat = 20% of energy) was more effective 
in increasing LDL-triglyceride levels in humans than high-saturated or 
high-polyunsaturated fat diets (40% of energy each). 
There were no significant changes in HDL-triglyceride levels when 
feeding high-saturated or high-polyunsaturated fat diets (31% of energy 
each) either to humans (Fisher et al., 1981) or monkeys (Ershow et al., 
1981). However, the addition of cholesterol to a high-saturated fat 
diet resulted in a significant elevation of HDL-triglyceride levels 
compared to a diet high in polyunsaturated fatty acids and cholesterol 
(Ershow et al., 1981). Dietary fat effects upon lipoprotein-triglycerides 
in various species are summarized in Table 2. 
Lipoprotein-cholesterol 
When comparing with a high-corn oil diet, feeding a diet high in 
coconut oil resulted in an increase in whole plasma- and VLDL-cholesterol 
levels in humans (Fisher et al., 1981). Similar results were observed 
in rats which were fed high-beef tallow and high-corn oil diets (Koh 
and Chi, 1981). Plasma-cholesterol levels were only slightly higher in 
diabetic compared to normal monkeys regardless of diet, and in both 
groups, cholesterol levels were lowest when a low-fat diet was fed but 
highest when a high-saturated fat diet (P/S ratio of 0.53) was fed 
(Howard, Jr., 1979). A high-polyunsaturated fat diet (P/S ratio of 2.4) 
compared to a high-saturated fat diet (P/S ratio of 0.2) significantly 
decreased total plasma-cholesterol levels which was largely due to a 
decrease in VLDL- and LDL-cholesterol in a study by Chait et al. (1974). 
Similar results were observed by Shepherd et al. (1978). Turner et al. 
Table 2. Summary of recent reports of dietary fat effects upon lipoprotein-triglycerides 
Plasma or Saturated fat vs. Dietary cholesterol 
lipoprotein polyunsaturated fat (if reported) Reference 
Plasma NS® (monkey) None Ershow et al., 1981 
(normal and < 0.01% Howard, Jr., 1979 
diabetic monkeys 
(rat) — Koh and Chi, 1981 
f (human) 400 mg/day Shepherd et al., 1978, 1980 
NS (human) < 150 mg/day Turner et al., 1981 
VLDL (human) — Chalt et al., 1974 
t (human) None Fisher et al., 1981 
LDL NS (human) — Chait et al., 1974 
NS (monkey) None Ershow et al., 1981 
(human) None Fisher et al., 1981 
HDL NS (monkey) None Ershow et al., 1981 
f (monkey) 300 mg/1000 kcal diet Ershow et al., 1981 
NS (human) None Fisher et al., 1981 
^NS = not statistically significant. 
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(1981), however, reported no significant impact of polyunsaturated fat 
feeding (P/S ratio of 8.0 vs. 0.2) on VLDL-cholesterol levels in humans. 
Cholesterol levels were higher in VLDL when a low-fat diet rather than 
diets high in saturated or polyunsaturated fatty acids were fed to 
healthy humans (Brussaard et al., 1980). All diets contained about the 
same amount of cholesterol. 
High-saturated fat compared to high-polyunsaturated fat feeding 
resulted in a marked increase in LDL-cholesterol levels both in humans 
(Fisher et al., 1981; Illingworth et al., 1981) and rats (Koh and Chi, 
1981). The diets in the human studies were cholesterol-free. Illing­
worth et al. (1981) reported that compared to a high-saturated fat diet, 
a monounsat ur a ted fat diet lowered LDL-cholesterol less than a poly­
unsaturated fat diet. After diets with P/S ratios of 0.25, 1, or 3 
were fed to healthy humans for 3 to 4 weeks, LDL ratios of choiesteryl 
ester to free cholesterol were lowest at P/S ratio of 3 and highest at 
P/S ratio of 0,25 (Shore et al., 1981). Ershow et al. (1981) reported 
a significant rise in the choiesteryl ester fraction of LDL after feeding 
monkeys a diet high in coconut oil and cholesterol. Both Chait et al. 
and Shepherd et al. (1978, 1980) reported that feeding high-polyun­
saturated compared to high-saturated fat diets to humans resulted in a 
significant decrease in LDL-cholesterol. As with the VLDL data, 
cholesterol was higher in LDL when a low-fat diet rather than diets 
high in saturated or polyunsaturated fatty acids were fed to humans 
(Brussaard et al., 1980). 
Degree of saturation of high-fat diets (diets without cholesterol) 
had no effect on HDL-cholesterol levels either in humans (Fisher et al., 
25 
1981; Illingworth et al., 1981) or rats (Koh and Chi, 1981), Shepherd 
et al. (1978, 1980) observed a decrease in human HDL-cholesterol levels 
by feeding a high-polyunsaturated fat diet (P/S ratio of 4.0) compared to 
a high-saturated fat diet (P/S ratio of 0.25). Shepherd's diets, how­
ever, contained 400 mg cholesterol per day. Dietary fat effects upon 
lipoprotein-cholesterol in various species are summarized in Table 3. 
Fat vs. cholesterol in diet 
Ershow et al. (1981) reported that neither saturated fat (coconut 
oil) nor cholesterol alone substantially altered plasma-cholesterol 
levels. Together, however, these dietary components interacted 
synergistically to produce a significant elevation in plasma-cholesterol. 
Anderson et al. (1976) compared addition of cholesterol to cholesterol-
free diets in young men fed saturated or polyunsaturated fat as 40% 
of energy. The polyunsaturated fat resulted in about 30% reduction in 
serum-cholesterol compared to saturated fat while addition of 300 mg/day 
of dietary cholesterol caused a 5% increase compared to cholesterol-
free diet regardless of fat type. Oh et al. (1982) also observed that 
degree of dietary fat saturation had greater effects on plasma-cholesterol 
levels than dietary cholesterol. 
Lipoprotein-protein 
Apo-B Since apoproteins have structural and regulatory functions 
in lipid metabolism, they cannot be overlooked when studying effects of 
dietary fat on plasma-lipid levels. Cholesterol-free diets, which 
were either high in saturated (coconut oil, 14% per weight) or poly­
unsaturated fat (safflower oil, 15% per weight), had no significant 
Table 3. Summary of recent reports of dietary fat effects upon llpoprotein-cholesterol 
Plasma or Saturated fat vs. Dietary cholesterol 
lipoprotein polyunsaturated fat; (If reported) Reference 
Plasma t(human) 
^(human) 
NS^ (monkey) 
4(monkey) 
f(human) 
NS (normal and 
diabetic monkeys) 
r (rat) 
^ (human 
f (human) 
None or 300 mg/day 
None 
300 mg/kcal diet 
None 
< 0.01% 
1000 mg or 300 mg/day 
400 mg/day 
Anderson et al., 1976 
Chait et al., 1974 
Ershow et al., 1981 
Ershow et al., 1981 
Fisher et al., 1981 
Howard, Jr., 1979 
Koh and Chl, 1981 
Oh et al., 1982 
Shepherd et al., 1978 
VLDL ^ (human) 
f (rat) 
^ (human) 
NS (human) 
None 
400 mg/day 
< 150 mg/day 
Fisher et al., 1981 
Koh and Chl, 1981 
Shepherd et al., 1978 
Turner et al., 1981 
LDL f (human) 
^(human) 
>1* (human) 
f(rat) 
'i' (human) 
None 
None 
40 mg/day 
Chait et al., 1974 
Fisher et al., 1981 • 
Illingworth et al., 1981 
Koh and Chl, 1981 
Shepherd et al., 1978 
HDL NS (human) 
NS (rat) 
NS (human) 
^ (human) 
None 
None 
400 mg/day 
Fisher et al., 1981 
Koh and Chl, 1981 
Illingworth et al., 1981 
Shepherd et al., 1978, 1980 
^NS = not statistically significant. 
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effects on apo-B levels in VLDL, LDL or HDL of Mongolian gerbils (Nicolosi 
et al., 1981). However, feeding the high safflower oil diet tended to 
increase apo-B levels in VLDL and HDL. Similar results in VLDL were 
obtained by Chait et al. (1974) in humans. On the other hand, feeding 
polyunsaturated compared to saturated fat diets with (Shepherd et al., 
1980; Shore et al., 1981) and without cholesterol (Illingworth et al., 
1981) resulted in a decrease in total apo-B and LDL-apo-B levels 
(Shepherd et al., 1980). Carbohydrate-induced hypertriglyceridemia was 
associated with elevations of VLDL-apo-B levels (Brussaard et al., 1980; 
Getz and Hay, 1979) but Brown (1980) found no changes in VLDL-apo-B 
production in humans consuming a high-carbohydrate diet. 
Apo-E The accumulation of apo-E in hypercholesterolemic 
rats fed a high-saturated fat diet (butter fat and cholesterol) 
compared to rats fed a Purina Chow diet (Wong and Rubinstein, 1979) 
has been attributed to an increase in apo-E secretion rather than a 
decrease in catabolism. In the Mongolian gerbil (Nicolosi et al., 1981), 
a high-coconut oil diet tended to increase VLDL-apo-E but decrease LDL-
apo-E levels compared to a high-safflower oil diet. Both diets were 
cholesterol-free. Compared to a high-corn oil diet, plasma-apo-E levels 
were elevated in rhesus monkeys fed a cholesterol-free diet high in coconut 
oil (Zannis et al., 1981). Fisher et al. (1981) reported an increase in 
apo-E levels primarily in human VLDL but also in LDL but not in HDL when 
a high-coconut oil rather than a high-corn oil diet (31% of energy each) 
was consumed over a period of 18 days. The intake of a high-carbohydrate, 
liquid-formula diet (85% carbohydrate and 15% protein) resulted in an 
elevation of VLDL-apo-E but not plasma-apo-E levels (Falko et al., 1980). 
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Apo-C Apo-C, or lew molecular weight apoproteins, were signifi­
cantly higher in HDL of Mongolian gerbils fed the high-saturated compared 
to the high-polyunsaturated fat diet (Nicolosi et al., 1981). Diet, 
however, had no effect on apo-C levels in VLDL and LDL (Nicolosi et al., 
1981). Isocaloric substitution of dietary saturated, monounsaturated and 
polyunsaturated fatty acids had no effect on human plasma-apo-CIII 
levels (Illingworth et al., 1981). Compared to high-saturated fat 
diets, high-polyunsaturated fat diets tended to decrease levels of 
VLDL-apo-C (Chait et al., 1974) and HDL-apo-CIII (Illingworth and 
Connor, 1980). Among C apoproteins, apo-CII levels were higher in 
carbohydrate-induced VLDL than in control VLDL (Schonfeld et al., 1976). 
Apo-A Human plasma-apo-AI levels were not affected by feeding 
diets high in saturated, monounsaturated or polyunsaturated fatty 
acids (Illingworth et al., 1981). There was significantly less apo-AI 
in HDL of gerbils fed coconut oil (cholesterol-free) compared to safflower 
oil (cholesterol-free) containing diets (Nicolosi et al., 1981). On 
the other hand. Shepherd et al. (1978) reported a decrease in plasma-
apo-AI levels in humans when polyunsaturated fat rather than saturated 
fat containing diets were consumed- In the latter study, cholesterol 
was present in both types of diets. Dietary fat effects upon apo­
proteins in various species are summarized in Table 4. 
Lipoproteins and Disease 
Triglyceride and cholesterol levels in the plasma appear to be re­
lated independently to atherosclerotic vascular disease. Epidemiological 
Table 4. Summary of recent reports of dietary fat effects on apoproteins 
Saturated fat vs. 
Apoprotein polyunsaturated fat Species 
Apo-B t(plasma) Human 
NS® (VLDL, LDL, HDL) Gerbll 
^ (plasma, LDL) Human 
^(plasma) Human 
Apo-E t (VLDL, LDL) Human 
NS (HDL) Human 
NS (VLDL, LDL) Gerbll 
I (plasma) Monkey 
Apo-C NS (plasma-apo-GUI) Human 
NS (VLDL, LDL) Gerbll 
i (HDL) Gerbll 
Apo-A NS (plasma-apo-Al) Human 
i (HDL-apo-Al) Gerbll 
T (plasma-apo-AI) Human 
Dietary cholesterol 
(If reported) Reference 
None Illlngworth et al., 1981 
None Nlcolosl et al., 1981 
400 rag/day Shepherd et al., 1980 
300 mg/day Shore et al., 1981 
None Fisher et al., 1981 
None Flsher et al., 1981 
None Nlcolosl et al., 1981 
None Zannls et al., 1981 
None Illlngworth et al., 1981 
None Nlcolosl et al., 1981 
None Nlcolosl et al., 1981 
None Illlngworth et al., 1981 
None Nlcolosl et al., 1981 
400 mg/day Shepherd et al., 1978 
^NS = not statistically significant. 
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studies, such as the Stockholm Prospective Study (Carlson and Bottiger, 
1981) showed that elevated plasma-triglyceride levels were a risk factor 
for ischemic heart disease. 
The catabolism of LDL, which is usually the major cholesterol 
carrying vehicle in the plasma, occurs in peripheral cells and in the 
liver (Brewer, Jr., 1981). Excess deposition of cholesterol in and 
around cells of the arterial wall can lead to atherosclerotic lesions. 
Thus, populations with hi^ LDL levels are at greater risk of developing 
coronary heart disease (Getz and Hay, 1979). 
On the other hand, results of epidemiological studies (Heiss et al., 
1980) have suggested a protective role of HDL, which is mediated by a 
reverse transport of cholesterol from cells to HDL and ultimately to the 
liver for final excretion. Brewer, Jr. (1981) suggested that the 
protective effect of HDL could be primary via direct mediation by a 
component within HDL, or secondary via the effectiveness of lipolysis 
of triglyceride-rich lipoproteins of intestinal and liver origin. 
Calculations, however, from a computerized mathematical model (Verdery, 
1981), which included fibroblasts, HDL and LCAT, did not prove or dis­
prove that cholesterol loss from peripheral tissue proceeds as described 
by Glcanset (1979). 
Effects of Diabetes and Diet on Plasma Glucose and Insulin Levels 
Plasma glucose tends to be abnormally elevated in all types of 
diabetes. In insulin-dependent diabetes (untreated juvenile-type 
diabetes and experimental diabetes), plasma insulin levels are subnormal 
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or deficient, and in noninsulin-dependent diabetes (adult-onset type 
diabetes), insulin levels are usually increased above normal (Nikkila, 
1973). In insulin-dependent diabetic patients, insulin therapy generally 
results in normalization of the plasma lipid profile (Weidman et al., 
1982). 
In monkeys (Howard, Jr., 1979), amount and degree of saturation of 
fat in the diet had no significant effect on fasting plasma glucose levels. 
Nevertheless, plasma glucose levels tended to be highest in animals fed 
high-saturated fat (coconut oil, P/S ratio of 0.53), intermediate in 
those fed low-fat and lowest in those fed polyunsaturated fat diets 
(safflower, P/S ratio of 1.18). Similar results were obtained with 
plasma insulin levels, which tended to be highest in low-fat-fed, 
intermediate in saturated-fat-fed and lowest in polyunsaturated-fat-fed 
monkeys (cholesterol concentration in all diets was less than 0.01%). 
In humans (Chait et al., 1974), polyunsaturated fat feeding (P/S ratio 
of 2.4) tended to decrease plasma insulin levels compared to a diet 
high in saturated fat (P/S ratio of 0.2). 
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MATERIALS AND METHODS 
Experimental Plan 
The main objective of this study was to make comparisons of dietary and 
insulin-deficiency types of hyperlipidemia by investigating plasma glucose, in­
sulin and lipoprotein lipids and proteins in adult normal and streptozotocin-
induced diabetic male breeder rats. It is hypothesized that excess intake of 
a diet too high in saturated fat or too low in polyunsaturated fat may 
contribute to a metabolic pattern resembling that of a diabetic state. 
Animal selection 
The normal adult virgin rat is not very prone to hyperlipidemia 
probably because of its relatively low plasma-VLDL and LDL levels. Male 
breeder rats, which will develop advanced metabolic and degenerative 
changes as early as six to seven months of age, have been shown to have 
higher plasma-triglyceride and cholesterol levels than virgin male rats 
of the same age (Wexler, 1976). One might speculate that changes in 
lipid metabolism due to dietary fat will be more severe in breeder 
than virgin rats. Male breeder rats were, therefore, thought to be a 
proper model to study comparisons of dietary and insulin-deficiency types 
of hyperlipidemia. Six-to eight-month-old Wistar/Sprague-Dawley derived 
male breeder rats and streptozotocin-induced diabetic male breeder 
rats from the same stock colony were used as animal models of hyper-
lipidemia. Male rats were used for mating every seven weeks starting 
at 10 weeks of age. Males were left with females for 10 days during each 
breeding period. 
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Experimental Protocol 
The hypothesis to be tested was that excess intake of high-saturated 
fat diets may contribute to a metabolic pattern resembling that of a 
diabetic state. Insulin-dependent but also noninsulin-dependent diabetic 
subjects are often hyperlipidemic with defects primarily in triglyceride 
metabolism. If the hypothesis mentioned above is true, one would expect 
changes in blood lipid metabolism in subjects fed high-saturated fat 
diets that are similar to changes found in a diabetic state. 
Changes from low-fat stock to high-fat diets 
Prior to the study, all rats consumed a low-fat stock ration (Reeves 
and Amrich, 1974). In order to ensure that consumption of a high-
saturated fat diet is responsible for changes in blood lipid metabolism 
which resemble those in a diabetic state, one also has to investigate 
how a high-polyunsaturated fat diet or a low-fat purified diet might 
affect blood lipid metabolism. Thus, adult breeder rats were fed either 
a low-fat diet or diets high in beef tallow or hi^ in com oil for two 
months in order to assess a direct effect of amount and degree of satura­
tion of dietary fat on blood lipid metabolism. 
Switch of high-fat diets 
To accentuate effect of type of fat, another group of rats was fed 
first a high-saturated fat diet for two months and then switched to a 
high-polyunsaturated fat diet for another two months. The reverse switch 
(first polyunsaturated fat then saturated fat) was done with an addi­
tional group of rats. 
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Total amount of fat effects 
One also must consider the time factor of a feeding study. Does 
intake of high-fat diets, independent of P/S ratio, over four months 
have different effects on blood lipid metabolism than a two-month 
feeding study, canpared to low-fat feeding? 
Insulin-deficiency type of hyperlipidemia 
The streptozotocin-induced diabetic rats were considered a 
control group. The diabetic rats were necessary to compare animals fed 
the various experimental diets with animals known to be metabolically 
different through chemical induction of diabetes. 
Procedure 
Animals 
Animals were housed individually in meshwire cages at 24 + 1°C with 
12-hour light (0600 to 1800) and 12-hour dark (1800 to 0600) cycles. All 
rats had free access to water and were fed dzets ad lj.uj.tum. Cages were 
rotated within the animal room once a week. 
Experiment 1^ 
Twelve rats were made diabetic by injection of streptozotocin. The 
dose was sufficient to reduce plasma insulin to less than 5 w-U/ml and 
increase glucose to over 300 mg/dl plasma. Rats were then fed a stock 
ration (Reeves and Amrich, 1974) for two weeks. 
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Experiment 2 
Three groups of 24 rats each were fed either high-beef tallow, high-
corn oil or low-fat diet for two months. 
Experiment 2 
Twelve rats were fed high-beef tallow diet for two months and then 
switched to high-corn oil diet for another two months. 
Twelve rats were fed high-corn oil diet for two months and then 
switched to high-beef tallow diet for another two months. 
Diets 
Animals were randomly assigned to experimental diets which were 
instituted ad libitum. Composition of the diets is shown in Table 5. 
The approximate gross composition of the American diet (USA) was used for 
the weight percentage of the ingredients (U.S. Department of Agriculture, 
1969). The beef tallow diet contained about 38% of energy as beef fat 
and 2% as com oil which resulted in a polyunsaturated to saturated fat 
(P/S) ratio of about 0.2 (Dupont et al., 1972). The corn oil diet con­
tained about 40% of energy as polyunsaturated fat which provided a P/S 
ratio of about 5 (Dupont et al., 1972). 
Food Intake Study 
Food intake was measured twice over a total period of two weeks. 
Twelve rats within each group were selected randomly and food intake 
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Table 5. Composition of diets, weight percent 
Ingredient Low fat Beef tallow Com oil 
Lactalbumin^ 15.0 19.0 19.0 
Corn oil^ 1.0 1.2 21.2 
Beef tallow^ — 20.0 -
Salt mix*^ 4.0 5.0 5.0 
Cellulose^ 2.0 2.5 2.5 
Cornstarch^ 39.9 25.3 25,3 
Sucrose^ 36.5 25.0 25,0 
Vitamin mix® 1,6 2.0 2.0 
Kcal/g diet^ 4.229 5.383 5.383 
United States Biochemical Corporation, 21000 Miles Parkway, 
Cleveland, Ohio. 
^Mazola obtained from local retail market. 
^Beef tallow obtained from Carriage House Meat & Provision Co., 
Ames, Xowâ. 
*^Teklad, Madison, Wisconsin. Composition reported in Williams 
et al. (1968). Chromium at 0.3 ppm and selenium at 0.1 ppm were added. 
^Clinton Com Processing, 1251 Beaver Channel, Clinton, Iowa, 
^Friley Food Stores, Iowa State University, Ames, Iowa. 
^Contained per 2 kg of vitamin mixture made up with cornstarch: 
vitamin A acetate, 0.8g (500,000 lU/g); vitamin D (calciferol), 0.5g 
(400,000 lU/g); alpha-tocopherol acetate, 40.Og (500 lU/g); menadione, 
O.lg; vitamin ^ i2) lOg (0,1% trituration with mannitol); biotia, 0.05g; 
folic acid, 0.2g; p-aminobenzoic acid, 20.Og; inositol, 20.Og; Ca-
pantothenate, 2.0g; niacin, 3.0g; pyridoxine-HCl, l.Og; riboflavin, l.Og; 
thiamin-HCl, 0.5g; choline chloride 400.Og; ascorbic acid, 10.Og. 
^Calorie values of this formulation of diets were determined by 
bomb calorimetry (Parr Oxygen Bomb Calorimeter, Moline, Illinois). 
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was determined by weight of diet provided, minus that remaining and 
correcting for spillage. 
Experimental Diabetes Mellitus 
Twelve rats were rendered diabetic by a single i.v. injection of 
streptozotocin (gift of Dr. William Dulin, Upjohn Company, Kalamazoo, 
Michigan 49001, USA). Pilot studies with our rats suggested a strepto­
zotocin concentration of 30 mg/kg to be sufficient in inducing experi­
mental diabetes (about two weeks after injection, blood glucose concentra­
tion was approximately 340 mg/dl in 12-hour fasted rats). Streptozotocin 
was dissolved in 0.15M NaCl solution acidified to pH 4.5 with citrate 
and injected within five minutes after preparation of a fresh solution. 
Blood Samples 
Rats were fasted overnight (12 hours) and then anesthetized with 
ether. After exposure of the abdominal cavity, approximately 12 to 15 ml 
of blood per animal was drawn from the abdominal aorta into tubes con­
taining EDTA (1 mg/ml blood). Blood was handled at 4°C and centrifuged 
at low speed (SOOxg) for 15 minutes to remove platelets and red blood 
cells. Plasma samples from two rats within each group were combined 
for further analyses. Plasma glucose concentration was always assayed 
immediately and a small plasma sample was stored at -lô^C for insulin 
determination. Plasma was prepared for lipoprotein isolation within 
12 hours after blood sampling. 
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Lipoprotein Isolation 
Plasma lipoproteins were isolated into various density classes by 
repeated ultracentrifugation as previously described (Havel et al., 
1955). Ultracentrifugation was performed in a Beckman L-3 model ultra-
centrifuge with a rotor type 50Ti. The very low density lipoproteins 
(VLDL) were isolated at plasma density d < 1.006 g/ml by centrifugation 
at 40,000 rpm (106,000 x g; = 6 cm) for 18 hours. To eliminate 
albumin contamination, isolated VLDL were washed in saline with a salt 
density of 1.006 g/ml by centrifugation at 40,000 rpm for 18 hours. Other 
lipoprotein fractions were isolated by sequentially raising the plasma 
density to 1.063 and 1.21 g/ml by the addition of crystalline KBr. The 
d = 1.006 to 1.063 g/ml density fraction was obtained following ultra­
centrifugation at 40,000 rpm for 24 hours. The d = 1.063 to 1.21 g/ml 
fraction was isolated by ultracentrifugation at 40,000 rpm for 48 hours. 
The d = 1.063 to 1.21 g/ml fraction was recentrifuged for 24 hours 
at d = 1.21 g/ml to eliminate albumin contamination. Rotor chamber 
temperature was always 4°C. All fractions were removed by the tube-
slicing technique (National Heart and Lung Institute, 1974). The purity 
of the lipoproteins was judged by paper electrophoresis (Jencks and 
Durrum, 1955) in rats used in a separate study. 
Quantitation of Apoproteins 
Lipoproteins were extensively dialyzed against water with 0.017» 
EDTA pH 7.0 at 4°C and subsequently analyzed for their apoprotein con­
tent (Weisgraber and Mahley, 1978). Protein concentration was determined 
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using the Lowry method (Lowry et al., 1951). Proteins in each lipo­
protein fraction included primarily the apoproteins. Some samples, how­
ever , also contained trace amounts of albumin and other unidentified 
contaminants . Samples containing 20 iJ^g of protein were transferred into 
15 ml conical centrifuge tubes. After a Kimwipe was fastened on top of 
each tube, samples were frozen and then lyophilized for about 12 hours 
in a freeze dryer (VirTis Research Equipment, Gardiner, New York). 
Lyophilized samples were kept in the 15 ml conical centrifuge tubes 
and delipidated at 4°C by adding 1.5 ml of chloroform-.methanol, 2:1, 
V/V. After 30 minutes at 4°C, 1.5 ml of chilled Me OH was added and the 
samples were then centrifuged at 800xg for 15 minutes. Most of the 
solvent was removed by suction and protein pellets were dried with a 
gentle stream of nitrogen. Kimwipe was fastened on top of each centri­
fuge tube. As such, samples were stored in sealed jars containing 
anhydrous CaSO^ at -16°C for further analysis. 
Prior to electrophoresis, 100 pi of a buffer containing 2.5 nM 
tris, 19.2 mM glycine, 0.3% SDS-bromophenol blue solution was added to 
each sample. Samples were then incubated for 90 minutes at 37°C. Six 
to 8 grains of large crystal sucrose were added to each tube during the 
last 15 minutes of incubation to increase the density of the solution. 
The polyacrylamide gels contained 0.1% SDS (W/V), 0.19% N,N,N^,N^-
tetramethylethylenediamine (V/V) and 0.5% anmonium persulfate (w/V) in 
a buffer containing 24 mM Tris in 19.2 mM glycine (pH 8.3). An acrylamide 
to N,-methylene acrylamide (bis) ratio of 23.9 to 1 was used in the 
11% acrylamide gels (W/V). Reservoir solutions contained 0.5% SDS in a 
buffer containing 25 mM tris in 192 mM glycine (pH 8.3). 
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Samples were subjected to electrophoresis toward the anode at 150 
volts until one-half of the bromophenol blue dye marker had run off the 
bottom of the gel (about 1.5 to 2.0 hours). After electrophoresis, gels 
were fixed in a 40% methanol, 77» acetic acid aqueous solution for at 
least 10 hours, then stained by immersion for 2.0 hours in a solution 
containing 20 parts 50% aqueous methanol, 1 part glacial acetic acid and 
0.1% (W/V) Coomassie blue. The gels were destained for about two days 
in an aqueous solution containing 7.5% acetic acid and 5% methanol. 
The following standards of known molecular weight were used as 
reference proteins: Albumin (Bovine Plasma) — 66,000D; Albumin 
(Ovalbumin) — 45,000D; Pepsin (Porcine Stomach Mucosa) — 34,700D; 
Trypsinogen (Bovine Pancreas) — 24,000D; P-Lactoblobulin (Bovine Milk) — 
18,400D; Lysozyme (Egg White) — 14,300D; Insulin (Bovine Pancreas) — 
5,000D. All proteins were purchased from Sigma Chemical Company, Saint 
Louis, Missouri. 
The gels were analyzed for their apoprotein content by scanning of 
the apoprotein bands at a wavelength of 590 nm in a single-beam spectro­
photometer (Gilford Model 240, Oberlin, Ohio) equipped with a gel scanner 
(Gilford Model 2410, Oberlin, Ohio) and connected to a recorder (Gil­
ford Model 242, Oberlin, Ohio) and a Supergrater-1 Computer Integrator 
(Columbia Scientific Industries, Austin, Texas). 
With this method, apoproteins can be separated on the basis of size 
alone if they are first solubilized with the detergent sodium dodecyl-
sulfate (SDS). SDS binds to the molecules converting them to rod-like 
shapes and masking their native charge with its own negative charge. 
The proteins then become equal in charge density. When subjected to 
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polyacrylamide gel electrophoresis, apoproteins are then separated ac­
cording to size by the molecular sieving effects of the gel. In SDS 
electrophoresis, migration rate correlates quite accurately with molecular 
weight which makes this method suitable for molecular weight determina­
tions of unknown proteins. 
Analysis of apoprotein data 
Apoproteins analyzed in VLDL were apo-B, apo-E and apo-C. The 
different C-apoproteins (CI, CII, and CIII) did not resolve distinctly 
by SDS-polyacrylamide gel electrophoresis and were, therefore, col­
lectively called apo-C or low molecular weight apoproteins. LDL apo­
proteins analyzed were apo-B and apo-E, and apoproteins analyzed in 
HDL included apo-B, apo-E, apo-AI and apo-C. 
The apoproteins of LDL and HDL fractions may be converted to mass 
units by multiplying the relative area of each apoprotein by the mass 
determined for each lipoprotein fraction by the Lowry procedure. Quanti­
fying apoproteins by spectrophotometry, however, did not permit assess­
ment of absolute apoprotein mass in the VLDL fractions because equal 
sample sizes (20 p,g of protein) applied on the polyacrylamide gels did 
not always correlate with visual assessment of color density of protein 
bands after electrophoresis. Excess lipids in the VLDL fractions often 
caused cloudiness in the aqueous medium used in the protein determination 
assay. The extra cloudiness in addition to the color reagent (Lowry 
procedure) gave false high readings. Efforts were made to extract lipids 
from the VLDL fractions with ether before reading absorbances. 
It appeared that relative densities of apoproteins in each gel did 
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not change with different sample sizes. It was, therefore, possible to 
calculate relative amounts of apoproteins in each lipoprotein fraction 
by using the sum of all major apoproteins as a total and computing the 
percent of each apoprotein. 
Analysis of Lipids 
Chemical analysis of isolated lipoproteins included total and free 
cholesterol, triglycerides, phospholipids and protein. Moni-Trol-1 
Chemistry Control (DADE Division, American Hospital Supply Corporation, 
Miami, Florida) was used as a control to monitor accuracy and precision 
of individual assays. 
Cholesterol 
Total and free cholesterol were determined by sensitive enzymatic 
procedures which were slightly modified (Oh and Dupont, 1981) from the 
original methods described by Allain et al. (1974) and Carlson and 
Goldfarb (1977). In the reaction, cholesteryl esters are split by 
cholesteryl ester hydrolase and the total cholesterol is then oxidized 
by cholesterol oxidase. The liberated hydrogen peroxide is finally 
coupled with 4-aminoantipyrine and phenol in the presence of horseradish 
peroxidase to form a chromogenic quinoline dye with maximum absorption 
at 500 nm. Plasma- and lipoprotein-cholesterol can be quantitatively 
determined without extraction of lipids. Cholesteryl esters were as­
sumed to be the difference between total and free cholesterol. 
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Triglycerides 
Plasma- and lipoprotein-triglycerides were manually measured by a 
colorimetric procedure modified from the original method described by 
Giegel et al. (1975). With this method, lipids were first partitioned 
between a water/isopropanol and a heptane phase. A transesterifying 
agent, which consisted of NaOH in isopropanol, was used to liberate 
glycerol molecules from triglycerides. Glycerol was then oxidized by 
periodate (sodium periodate dissolved in acetic acid) and the formalde­
hyde produced was reacted with acetylacetone. The resulting chromogenic 
dye showed maximum absorption at 415 nm. 
Phospholipids 
Sandhu method A slightly modified procedure originally described 
by Sandhu (1976) was used to determine phospholipid concentrations in 
lipoproteins in experiments 2 and 3. Lecithin was used as a standard. 
A 100 (il sample was added to 1.5 ml of isopropanol. The entire supernatant 
was then used for phospholipid analysis. After evaporation, chloroform, 
chromogenic reagent and nonane were added to each sample. The chromogenic 
solution was composed of ammonium molybdate, HCl, mercury, H^SO^, methanol, 
chloroform and water. Maximum absorption of Prussian blue con^>lex formed 
was at 710 nm. 
In Sandhu's method, intact phospholipids are complexed with the 
chromogenic reagent which is soluble in organic solvent (nonane). This 
eliminates interference from inorganic phosphorous coming from plasma, 
reagents or glassware. 
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Bartlett method Phospholipids in lipoprotein fractions of the 
diabetic rats (experiment 1) were determined by a modified Bartlett 
phosphorous method (1959). Standards were prepared in absolute ethanol 
using Sigma Egg Yolk Lecithin III E. In the Bartlett method, acid 
digestion of lipids results in the conversion of all organic to inorganic 
phosphorous, making the chromogenic reagent complex water soluble. On 
the other hand, the phospholipid-chromogenic reagent complex in Sandhu's 
method is soluble in organic solvent. This prevents interference from 
inorganic phosphorous. Because of these methodological differences, 
phospholipid data from diabetic rats and animals fed the experimental 
diets were not compared. 
Analysis of Total Lipoprotein-Protein 
Protein was determined by the procedure of Lowry et al. (1951). 
Bovine serum albumin was used as the standard. Protein concentrations 
were used to calculate sample size for apoprotein quantitation. In 
this method, two distinct steps led to the final color with protein re­
sulting in a maximum absorption at 660 nm: reaction with copper in 
alkaline solution and reduction of the phosphomolybdic-phospho£ungstic 
reagent (Folin Reagent) by the copper treated protein. 
Especially in VLDL, excess lipids caused cloudy samples. If this 
occurred, lipids were then extracted first with ether before reading 
absorbances. 
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Analysis of Glucose 
Glucose was determined enzymatically using a Beckman Glucose Analyzer 
which is an electronic oxygen sensor device. When the sample is in­
jected into an enzyme reagent solution, glucose from the sample combines 
dissolved O2 from the solution. Gluconic acid and HgOg are then formed 
via the reaction of glucose and O2 in the presence of glucose oxidase. 
Og consumption is proportional to glucose concentration in the saiiq>le. 
To ensure destruction of the peroxide, ethanol, catalase, iodide and 
molybdate are added to the enzyme reagent solution. 
Analysis of Insulin 
An Insulin Radioimmunoassay Kit was used for the detection of 
insulin in plasma. The kit was purchased from Amersham Corporation, 
Arlington Heights, Illinois. A modification of the assay was neces­
sary, since the concentrations of immunoreactive insulin in the present 
study were low. This modification can be obtained from Amersham Corpora­
tion. The range of the human insulin standard concentrations was from 
0,5 to 160 p,l insulin/ml. Sample size was 100 y,l. In this modified 
procedure, samples of the unknown and standard insulin solutions were 
incubated with 0,1 ml of the insulin binding reagent at 4°C for 24 
125 
hours. Insulin- I (0.1 ml) was added and samples were incubated at 
4°C for an additional 72 hours. The 700 |i,l of cold buffer (4°C), 
consisting of 0.4% (W/V) bovine serum albumin in phosphate buffered 
saline (pH 7.4), was added to all tubes. The insulin binding reagent 
used in this procedure was an insoluble complex of guinea pig antibody 
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to insulin which had been reacted with a second rabbit antibody to the 
guinea pig antibody. The insoluble antigen-antibody complex was separated 
from the soluble free insulin by centrifugation at 2,000xg for 20 minutes 
in a refrigerated centrifuge (Beckman J-21B, Palo Alto, California). 
Radioactivity in the precipitate of both standards and unknowns was 
counted in a Gamma Counter (Beckman, Biogamma 11, Fullerton, California). 
A standard curve was constructed from which unknown insulin values 
were interpolated. 
The basic principles of RIA utilize the reaction between antigen 
and antibody. Since both the labeled insulin and the insulin present 
in the sample will compete for the limited number of antibody sites, 
the amount of radioactivity in the antigen-antibody complex will be 
an inverse factor of the antigen (insulin) concentration in the sample. 
Statistical Analysis 
Data were analyzed by using the analysis of variance and Student's 
t-test. The statistical program used was Statistical Analyzer System 
(SAS) User's Guide (Helwig and Council, 1979). Statistical probability 
of p < 0.05 was considered significant. In tables, data are reported 
as means with a value for pooled standard deviation (SD). For better 
visual evaluation of differences, the standard error of the mean was 
used in figures. 
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RESULTS 
Food Intake Study 
Rats fed high-fat diets consumed similar amounts of food per day 
(Table 6 and Figure 1). Dietary intake of low-fat (LF)-fed rats, however, 
was greater than in beef tallow (BT)- (p < 0.005) and com oil (CO)-
(p < 0.001) fed rats. There was no difference in food intake when 
data were expressed as kcal consumed per day (Figure 2). This was ex­
pected since the energy value of both the BT and CO diets was higher 
(5.383 kcal/g diet) than that of the LF diet (4.229 kcal/g diet). 
Table 6. Food intake of male breeder rats 
Food intake 
Treatment (n) g/day kcal/day 
BT (12) 20.5* 110.1* 
CO (12) 18.8* 101.2* 
LF (12) 25.1 106.0 
Pooled SD: 3.3 11.7 
Different superscripts indicate significantly different means (p<0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
Rat Body Weights 
Ignoring diets, the average initial (beginning of feeding study) 
body weight of the rats fed the experimental diets for two months (ex­
cluding NBT and NCO rats) was 619 + 72g. Diets had no effect on the 
Figure 1. Effects of dietary fat on food Intake of male breeder rats. Each variable is expressed as 
mean + standard error. There were 12 animals per variable. BT: rats fed high-beef tallow 
diet; CO: rats fed high-corn oil diet; LF: rats fed low-fat diet 
Figure 2. Effects of dietary fat on energy intake of male breeder rats. Each variable is expressed 
as mean + standard error. There were 12 animals per variable. BT; rats fed high-beef 
tallow diet; CO; rats fed high-corn oil diet; LF; rats fed low-fat diet 
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initial and final (end of feeding study) body weights. In general, all 
animals gained weight over the two-month feeding period (Figure 3). 
However, rats fed the high-fat diets appeared to gain more weight than 
animals fed the low-fat diet. Average weight gain (final minus initial 
body weight) over the two-month feeding period was significantly higher 
in CO (53g) and BT (42g) than LF (13g) (p < 0.001) rats (Table 7). 
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Figure 3. Illustration of effects of dietary fat on body weight of male 
breeder rats. Each data point represents the mean of 24 
rats (experiment 2). 
Plasma Glucose and Insulin 
Plasma glucose 
Diets had little effect on plasma glucose levels. However, plasma 
glucose was significantly higher (p < 0.001) in diabetic rats than in 
normal animals fed experimental diets (Table 8 and Figure 4). 
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Table 7. Body weights of male breeder rats at the beginning and end 
of the two-month feeding study 
Initial weight Final weight Difference 
Treatment (n) Gram 
BT (24) 607 649* 42® 
CO (24) 616* 669 53® 
LF (24) 633® 646® 13° 
Pooled SD; 72 73 25 
Different superscripts indicate significantly different means (p < 0.05 ) . 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
Plasma insulin 
Plasma insulin concentrations were not affected significantly by 
amount and degree of saturation of dietary fat but tended to be 
lower in BT-fed rats compared to CO- (p <0.2) and LF-fed (p < 0.1) 
animals (Table 8 and Figure 5). Fasting plasma insulin levels were 
significantly lower (p < 0.01) in diabetic rats compared to all other 
groups. 
Lipoprotein-Protein 
Protein values in lipoprotein fractions are summarized in Table 9. 
Diet had no effect on protein concentrations in LDL and HDL. Protein 
concentrations also were not different in the LDL and HDL between normal 
animals fed the experimental diets and the diabetic rats. There was 
significantly more VLDL-bound protein in BT- (p < 0.025), CO- (p < 0.05) 
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Table 8. Fasting plasma glucose and insulin concentrations of male 
breeder rats 
Glucose Insulin 
Treatment (n) mg/dl p-U/ml 
BT (12) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (6) 
129* 
125* 
129 
121* 
123* 
343 
8.7* 
10.1* 
12.0* 
::: 
4.8^ 
Pooled SD: 19 4.0 
Different superscripts indicate significantly different means 
(p < 0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
and LF-fed (p < 0.025) rats compared to NBT and NCO rats. There was, 
however, no dietary effect on VLDL-protein concentration between BT-
and CO-fed rats and also between NBT and NCO animals. In contrast to 
LUL and HDL, VLDL-protein concentration was significantly hi^er in 
diabetic rats than BT- (p < 0.05), CO- (p < 0.05), NBT- (p < 0.005) 
and NCO- (p < 0.005) but not LF-fed rats. 
Lipoprotein-Phospholipids 
Only the phospholipid data from normal rats fed the experimental 
diets are reported. Hiere was no dietary effect on phospholipid levels 
in any lipoprotein fraction (Table 10). 
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Figure 4. Effects of dietary fat and streptozotocin-induced diabetes 
on plasma glucose in 12-hour fasted male breeder rats. 
Each variable is expressed as mean + standard error. There 
were either 12 (BT, CO or LF) or 6 (NBT, NCO or D) animals 
per variable. BT: rats fed high-beef tallow diet; CO: 
rats fed high-corn oil diet; LF: rats fed low-fat diet; 
NBT: rats switched from CO to BT diet; NCO: rats switched 
from BT to CO diet; D: streptozotocin-induced diabetic 
rats. 
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Figure 5. Effects of dietary fat and streptozotocin-induced diabetes 
on plasma insulin in 12-hour fasted male breeder rats. Each 
variable is expressed as mean + standard error. There were 
either 12 (BT, CO or LF) or 6 (NBT, NCO or D) animals per 
variable. BT: rats fed high-beef tallow diet; CO: rats 
fed high-corn oil diet; LF: rats fed low-fat diet; NBT: 
rats switched from CO to BT diet; NCO: rats switched from 
BT to CO diet; D: streptozotocin-induced diabetic rats. 
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Table 9. Total protein content in lipoprotein fractions of male 
breeder rats 
VLDL LDL HDL 
Treatment (n) mg/dl plasma 
BT (12) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (6) 
Pooled SD: 4.1 2 . 8  9.2 
Different superscripts indicate significantly different means (p<0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
VLDL-cholesterol 
Animals fed the experimental diets appeared to contain more 
cholesteryl ester than free cholesterol in the VLDL fraction (Table 11 
and Figure 6). In diabetic rats, free cholesterol, however, pre­
dominated over cholesteryl ester. Diet had no effect on total cholesterol 
but there was significantly more total cholesterol in VLDL of diabetic 
rats compared to BT (p < 0.05) and NCO (p < 0.05) animals. Diet also 
had no effect on free cholesterol but levels of free cholesterol were 
significantly higher in diabetic rats (p < 0.001) compared to all other 
Lipoprotein-Cholesterol 
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Table 10. Lipoprotein phospholipids of male breeder rats 
VLDL LDL HDL 
Treatment (n) mg/dl plasma 
BT (12) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
Pooled SD: 4.1 2 . 1  9.4 
Different superscripts indicate significantly different means (p<0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
animals. There was no difference in cholesteryl ester levels among all 
animals. Dietary fat, differing in degree of saturation, therefore, 
did not affect VLDL-cholesterol levels. 
LDL-cholesterol 
In contrast to VLDL-cholesterol data, cholesteryl ester levels in 
LDL were higher than free cholesterol levels not just in animals fed 
the experimental diets but also in diabetic rats (Table 12 and Figure 7). 
LDL-total cholesterol levels were the same in normal animals fed the 
experimental diets but significantly lower in diabetic rats (p < 0.001) 
compared to all other animals. There was no dietary effect on free 
cholesterol levels, and among rats fed the experimental diets only, 
CO-fed rats had significantly more LDL-free cholesterol (p < 0.001) 
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Table 11. Plasma very low density lipoprotein-cholesterol of male 
breeder rats 
Total 
cholesterol 
Free 
cholesterol 
Cholesteryl 
ester 
Treatment (n) mg/dl plasma 
BT (12) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (6) 
Pooled SD: 3.1 1.9 1 .8  
Different superscripts indicate significantly different means (p < 0.05). 
BT: rats fed high-beef tallow diet. 
CO; rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
than diabetic rats. Cholesteryl ester levels also were not affected by 
diets but were significantly lower in diabetic (p < 0.001) compared to 
all other rats. Thus, amount and degree of saturation of dietary fat 
had no effect on LDL-cholesterol; however, a diabetic state resulted in 
a decrease in cholesteryl ester and thus total cholesterol in LDL. 
HDL-cholesterol 
In HDL, all animals exhibited more cholesteryl ester than free 
cholesterol (Table 13 and Figure 8). Diet did not affect total cholesterol 
levels but HDL of diabetic rats contained significantly less total 
cholesterol (p < 0.001) than HDL of the normal rats fed the experimental 
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Figure 6. Effects of dietary fat and streptozotocin-induced diabetes on 
VLDL-cholesterol in 12-hour fasted male breeder rats. Each 
variable is expressed as mean + standard error. There were 
either 12 (BT, CO or LF) or 6 (NBT, NCO or D) animals per 
variable. BT; rats fed high-beef tallow diet; CO; rats fed 
high-corn oil diet; LF; rats fed low-fat diet; NBT: rats 
switched from CO to BT diet; NCO; rats switched from BT to CO 
diet; D; streptozotocin-induced diabetic rats; FC; free 
cholesterol; CE; choiesteryl ester. 
diets. Free cholesterol levels were significantly higher in LF compared 
to BT (p < 0.025) and NBT (p <0.005) xats. Free cholesterol levels 
were also significantly higher in CO compared to BT (p < 0.05) and NBT 
(p < 0.01) rats. It appeared, therefore, that high-saturated fat but 
not high-polyunsaturated or low-fat diets caused a decrease in free 
cholesterol levels in HDL molecules. Free cholesterol levels were 
significantly lower in diabetic rats than all normal rats (p <0.001). 
Diet had no effect on HDL-choiesteryl ester levels which, however, were 
significantly lower in diabetic (p < 0.001) than all other rats. 
Diabetes, therefore, decreased HDL-cholesterol levels. 
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Table 12. Plasma low density lipoprotein-cholesterol of male breeder 
rats 
Total 
cholesterol 
Free 
cholesterol 
Cholesteryl 
ester 
Treatment (n) mg/dl plasma 
BT (12) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (6) i 1 1.6^ 1 
Pooled SD; 2.9 0.9 2.3 
Different superscripts indicate significantly different means 
(p <0.05). 
BT: rats fed high-beef tallow diet. 
CO; rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO; rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
Lipoprotein-XTiglycerides (TG) 
VLDL-triglycerides 
There was no significant dietary effect on VLDL-TG levels (Table 14 
and Figure 9). VLDL-TG levels were, however, significantly higher in 
diabetic rats (p < 0.001) compared to normal animals fed experimental 
diets. 
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Figure 7. Effects of dietary fat and streptozotocin-induced diabetes on 
LDL-cholesterol in 12-hour fasted male breeder rats. Each 
variable is expressed as mean + standard error. There were 
either 12 (BT, CO or LF) or 6 (NBT, NCO or D) animals per 
variable. BT: rats fed high-beef tallow diet; CO; rats fed 
high-corn oil diet; LF: rats fed low-fat diet; NBT: rats 
switched from CO to BT diet; NCO: rats switched from BT to 
CO diet; D: streptozotocin-induced diabetic rats; FC: free 
cholesterol; CE: cholesteryl ester. 
LDL-triglycerides 
LDL-TG levels were significantly lower in CO- (p < 0.025) and LF-fed 
(p <0.001) rats compared to BT-fed rats (Table 14 and Figure 10). A 
dietary change frcm CO to BT (=NBT) resulted in a significant (p <0.001) 
elevation of LDL-TG, with NBT similar to the diabetic rats. LDL-TG 
levels in NBT rats were also significantly higher than in BT- (p < 0.005), 
CO- (p < 0.001) and LF-fed (p < 0.001) rats. TG levels in LDL were 
significantly higher in diabetic rats compared to BT (p <0.001), CO 
(p <0.001), LF (p < 0.001) and NCO (p <0.001) but not NBT rats. High-
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Table 13. Plasma high density lipoprotein-cholesterol of male breeder 
rats 
Total 
cholesterol 
Free 
cholesterol 
Choiesteryl 
ester 
Treatment (n) mg/dl plasma 
BT (12) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (6) 
30.8* 
31.0 
33.5 
28.4* 
35.8* 
17.7b il 
24.6* 
23.0 
25.3 
23.3 
28.6* 
15.1^ 
Pooled SD: 7.5 2.0 6.1 
Different superscripts indicate significantly different means 
(p < 0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
saturated fat feeding, therefore, led to an increase in LDL-TG levels 
similar to a diabetic state. 
HDL-triglycerides 
In contrast to VLDL- and LDL-TG, there was no dietary effect on 
HDL-TG levels (Table 14 and Figure 11). However, HDL-TG levels were 
significantly lower in diabetic (p < 0.001) compared to all other rats. 
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HDL-CHOLESTEROL 
Figure 8. Effects of dietary fat and streptozotocin-induced diabetes on 
HDL-cholesterol in 12-hour fasted male breeder rats. Each 
variable is expressed as mean + standard error. There were 
either 12 (BT, CO or LF) or 6 (NET, NCO or D) animals per 
variable. BTs rats fed liigh—beef tallowj CO: rats fed high-
corn oil diet; LF; rats fed low-fat diet; NBT: rats switched 
from CO to BT diet; NCO: rats switched from BT to CO diet; 
D: streptozotocin-induced diabetic rats; FC; free 
cholesterol; CE: cholesteryl ester. 
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Table 14. Plasma lipoprotein—triglycerides of male breeder rats 
VLDL LDL HDL 
Treatment (n) mg/dl plasma 
BT (12) . 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (6) 
Pooled SD; 31.8 0.7 0 .6  
Different superscripts indicate significantly different means (p<0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF; rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
Figures 12-14 illustrate sangles of apoproteins from different lipo­
protein fractions as they appeared after electrophoretic migration. 
Major detectable apoproteins were apo-B, apo-E and apo-C in VLDL, apo-B 
and apo-E in LDL, and apo-B, apo-E, apo-AI and apo-C in HDL. A major 
decrease in intensity of apo-E bands both in LDL and HDL was apparent 
in diabetic rats compared to animals fed the experimental diets. 
VLDL-apoproteins 
Generally, diet and streptozotocin-induced diabetes had little 
effect on apo-B (Table 15 and Figure 15). However, percent of apo-B 
Lipoprotein-Apoproteins 
Figure 9. Effects of dietary fat and streptozotocin-induced diabetes on 
VLDL-triglyceride level in 12-hour fasted male breeder rats. 
Each variable is expressed as mean + standard error. There 
were either 12 (BT, CO or LF) or 6 (NBT, NCO or D) animals 
per variable. BT: rats fed high-beef tallow diet; CO: 
rats fed high-corn oil diet; LF; rats fed low-fat diet; 
NBT; rats switched from CO to BT diet; NCO; rats switched 
from BT to CO diet; D; streptozotocin-induced diabetic rats. 
Figure 10. Effects of dietary fat and streptozotocin-induced diabetes 
on LDL-triglyceride level in 12-hour fasted male breeder 
rats. Each variable is expressed as mean + standard error. 
There were either 12 (BT, CO or LF) or 6 (NBT, NCO or D) 
animals per variable. BT; rats fed high-beef tallow diet; 
CO; rats fed high-corn oil diet; LF; rats fed low-fat 
diet; NBT: rats switched from CO to BT diet; NCO: rats 
switched from BT to CO diet; D; streptozotocin-induced 
diabetic rats. 
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Figure 11. Effects of dietary fat and streptozotocin-induced diabetes 
on HDL-triglyceride level in 12-hour fasted male breeder 
rats. Each variable is expressed as mean + standard error. 
There were either 12 (BT, CO or LF) or 6 (NBT, NCO or D) 
animals per variable. BT: rats fed high-beef tallow diet; 
CO: rats fed high-corn oil diet; LF: rats fed low-fat 
diet; NBT: rats switched from CO to BT diet; NCO: rats 
switched from BT to CO diet; D: streptozotocin-induced 
diabetic rats. 
was significantly lower in LF than BT (p < 0.05) and diabetic (p <0.005) 
rats. Overall, apo-B appeared to be higher in BT, NBT and diabetic 
rats compared to all other animals. Feeding the three experimental 
diets for two months caused no difference in apo-E levels in VLDL frac­
tions. Also, apo-E levels were the same in BT-, CO- and LF-fed and 
diabetic rats. However, NBT and NCO rats which were fed high-fat diets 
(differing only in degree of saturation) for a total of four months had 
significantly higher apo-E levels than animals fed either BT (NBT vs. 
BT, p <0.01; NCO vs. BT, p < 0.005) or CO (NBT vs. CO, p < 0.025; NCO 
vs. CO, p < 0.005) diets for two months. Apo-E levels also were higher 
in NBT (p < 0.01) and NCO (p <0.005) rats compared to diabetic animals. 
Similar to the apo-E data, significant differences were observed 
with the apo-C (or low molecular weight apoproteins) data between animals 
66 
Apo-B 
Apo-E 
# • 
W g 
Apo-C 
VLDL VLDL VLDL VLDL VLDL VLOL 
BT CO LF NBT' NCO D 
Figure 12. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
of rat VIiDL. Approximately 25 pg of lipoprotein protein 
was applied to each gel. Apoproteins are illustrated in 
sample gels. BT: rats fed high-beef tallow diet; CO; 
rats fed high-corn oil diet; LF: rats fed low-fat diet; 
NBT: rats switched from CO to BT diet; NCO; rats switched 
from BT to CO diet; D: streptozotocin-induced diabetic 
rats. 
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Figure 13. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
of rat LDL. Approximately 25 wg of lipoprotein protein was 
applied to each gel. Apoproteins are illustrated in sample 
gels. BT: rats fed high-beef tallow diet; CO; rats fed 
high-corn oil diet; LF: rats fed low-fat diet; NBT: rats 
switched from CO to BT diet; NCO: rats switched from BT to 
CO diet; D: streptozotocin-induced diabetic rats 
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Figure 14. Sodium dodecyl sulfate polyacrylajnide gel electrophoresis 
of rat HDL. Approximately 25 pig of lipoprotein-protein 
was applied to each gel. Apoproteins are illustrated in 
sample gels. BT; rats fed high-beef tallow diet; CO; 
rats fed high-corn oil diet; LF; rats fed low-fat diet; 
NBT; rats switched from CO to BT diet; NCO; rats switched 
from BT to CO diet; D: streptozotocin-induced diabetic 
rats. 
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Table 15. VLDL-apoproteins of male breeder rats 
Apo-B Apo-E Apo-C 
Treatment (n) Percent of total apoproteins 
BT (10) 
CO (10) 
LF (10) 
NBT (6) 
NCO (6) 
D (6) 52.8* 
14.0 
27.0: 
13.4* 
7.0 Pooled SD: 11.6 
Different superscripts indicate significantly different means (p<0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched frmn BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
fed high-fat diets for two and four months. In contrast to apo-E, 
apo-C was lower in NBT (p < 0.05) than CO rats. Apo-C levels were 
highest in LF-fed animals and lowest in diabetic rats and animals fed 
high-fat diets over a four-month period. More specifically, LF-fed 
rats contained significantly more VLDL-bound apo-C than NBT (p < 0.005) 
and NCO (p < 0.025) and also diabetic rats (p < 0.025). 
LDL-apoproteins 
The major apoprotein in rat LDL appeared to be apo-B (Table 16 and 
Figure 16). As with the VLDL fraction, apo-B levels were not different 
in rats fed BT or CO diets. Feeding the LF diet caused, however, a 
significant decrease in apo-B levels compared to BT- (p < 0.005) or CO-
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Figure 15. Effects of dietary fat and streptozotocin-induced diabetes 
on VLDL-apoproteins in 12-hour fasted male breeder rats. 
Each variable is expressed as mean + standard error. There 
were either 10 (BT, CO or LF) or 6 (NBT, NCO or D) animals 
per variable. BT: rats fed high-beef tallow diet; CO; 
rats fed high-corn oil diet; LF: rats fed low-fat diet; 
NBT: rats switched from CO to BT diet; NCO: rats switched 
from BT to CO diet; D: streptozotocin-induced diabetic 
rats. 
(p < 0.025) fed rats. Apo-B levels were significantly higher in diabetic 
rats compared to all normal rats (p < 0.005). 
In contrast to apo-B data, apo-E levels were significantly lower 
in streptozotocin-induced diabetic animals compared to all normal rats 
(p < 0.005) or CO- (p < 0.025) fed rats and percent of LDL-bound apo-E 
was the same in rats fed the BT and CO diets. Therefore, only amount of 
fat but not the degree of saturation of dietary fat affected apo-B and 
apo-E levels in LDL. However, diabetes led to an increase in apo-B and 
Apo-E levels ware significantly higher in LF- than BT-
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Table 16. LDL-apoprotelns of male breeder rats 
Apo-B Apo-E 
Treatment (n) 
Percent of total 
apoproteins 
BT (12) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (4) 
Pooled SD: 16.5 16.5 
Different superscripts indicate significantly different means (p<0.05). 
BT: rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF: rats fed low-fat diet. 
NBT: rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rat. 
a decrease in apo-E levels which was significant compared to animals fed 
the experimental diet. 
HDL-apoproteins 
Apo-B, apo-E, apo-AI and apo-C were the apoproteins analyzed in HDL 
(Table 17 and Figure 17). Apo-AI appeared to be the major apoprotein in 
rat HDL. Only trace amounts of apo-B were present in most samples. Diet 
had no effect on apo-B but apo-B levels were significantly higher in 
diabetic rats (p <0.005) compared to all other animals. Apo-E levels 
were not different in rats fed the high-fat diets over a two- or four-
month period. However, apo-E levels were significantly higher in LF-fed 
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Figure 16. Effects of dietary fat and streptozotocin-induced diabetes 
on LDL-apoproteins in 12-hour fasted male breeder rats. 
Each variable is expressed as mean + standard error. There 
were either 12 (BT, CO or LF), 6 (NBT or NCO) or 4 (D) 
animals per variable. BT: rats fed high-beef tallow diet; 
CO; rats fed high-corn oil diet; LF: rats fed low-fat 
diet; NBT: rats switched from CO to BT diet; NCO: rats 
switched from BT to CO diet; D: streptozotocin-induced 
diabetic rats. 
rats compared to BT (p <0.001), CO (p <0.001), NBT (p < 0.001) and 
NCO (p < 0.001) rats. Apo-E was almost nondetectable in HDL of diabetic 
rats, whereas HDL of all other rats contained major amounts of apo-E. 
Thus, apo-E was significantly lower in diabetic (p <0.001) compared to 
all other animals. Apo-Al levels were always more than twice as high 
as apo-E levels in all rats except the LF-fed animals in which there 
was no difference. Percent of apo-AI appeared to be highest in diabetic 
rats and lowest in LF-fed animals. Apo-AI was significantly lower in 
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Table 17. HDL-apoproteins in male breeder rats 
Apo-B Apo-E Apo-AI Apo-C 
Treatment (n) Percent of total apoproteins 
BT (11) 
CO (12) 
LF (12) 
NBT (6) 
NCO (6) 
D (6) 
Pooled SD: 3.6 8.4 9.9 5.1 
Different superscripts indicate significantly different means (p<0.05). 
BT: rats fed high-beef tallow diet. 
CO; rats fed high-corn oil diet. 
LF; rats fed low-fat diet. 
NBT; rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
LF than BT (p <0.001), CO (p <0.001), NBT (p < 0.001) and NCO 
(p < 0.001) rats. Diabetic rats had significantly higher apo-AI levels 
than CO- (p < 0.005) and LF- (p < 0.001) but not BT-fed rats. There was 
no dietary effect on apo-C levels except in LF and NCO rats, with higher 
apo-C levels in LF (p < 0.05) than NCO rats. Apo-C levels were signifi­
cantly higher in diabetic rats than all normal animals (p <0.001). 
Triglyceride Metabolism 
Lipid and protein values in different lipoprotein fractions may 
reflect the status of triglyceride metabolism. For example, a comparison 
between cholesterol values in HDL (HDL-TC) and triglyceride values in 
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Figure 17. Effect of dietairy fat and streptozotocin-induced diabetes on 
HDL-apoproteins in 12-hour fasted male breeder rats. Each 
variable is expressed as mean + standard error. There were 
either 11 (BT), 12 (CO or LF) or 6 (NBT, KCO or B) animals 
per variable. BT: rats fed high-beef tallow diet; CO: rats 
fed high-corn oil diet; LF: rats fed low-fat diet; NBT: 
rats switched from CO to BT diet; NCO: rats switched from BT 
to CO diet; D: streptozotocin-induced diabetic rats. 
VLDL (VLDL-TG) has been suggested to be an informative indicator of the 
efficiency of the degradation of triglyceride-rich lipoproteins (Alaupovic, 
1981). Defective clearance of triglyceride-rich lipoproteins would re­
sult in lower concentrations of HDL-cholesterol. 
During lipolysis, apo-B remains with VLDL to become LDL (Brewer, Jr., 
1981). The ratios VLDL-TG/LDL-TG and VLDL-âpo-B/LDL-apo-B, therefore. 
can be used to estimate lipolytic rate or lipoprotein lipase activity. 
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HDL-TC/VLDL-TG 
The ratio of total cholesterol in HDL divided by triglyceride in 
VIiDL was not affected by amount and degree of saturation of dietary fat 
(Table 18). Comparing the two high-fat diets, however, CO feeding 
tended (p < 0.2) to result in a larger ratio than BT feeding. The 
HDL-TC/VLDL-TG ratio was significantly lower (p < 0.001) in diabetic 
rats compared to all animals fed the experimental diet. 
VLDL-TG/LDL-TG 
The VLDL-TG/LDL-TG ratio (Table 18) was significantly higher in LF 
compared to BT (p < 0.01), NBT (p <0.005), CO (p < 0.05) and NCO 
Table 18. Ratios of selected lipoprotein lipids and proteins of male 
breeder rats 
Treatment (n) HDL-TC/VLDL-TG VLDL-TG/LDL-TG VLDL-apo-B/LDL-apo-B 
BT (12) 0.61 16.9* 0.60' 
CO (12) 0.75* 19.9* 0.59' 
LF (12) 0.58" 29.6" 0.64' 
NBT (6) 0.60 12.0* 0.69' 
NCO (6) 0.80* 16.7* 0.62 
D (6) . 0.23b 17.6 0.55 
Pooled SD: 0.24 10.7 0.22 
Different superscripts indicate significantly different means (p < 0.05). 
BT; rats fed high-beef tallow diet. 
CO: rats fed high-corn oil diet. 
LF; rats fed low-fat diet. 
NBT; rats switched from CO to BT diet. 
NCO: rats switched from BT to CO diet. 
D: streptozotocin-induced diabetic rats. 
TC: total cholesterol. 
TG: triglyceride. 
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(p < 0.025) rats. There was no difference between BT- and CO-fed rats 
and between rats fed the high-fat diets and diabetic animals. The 
VliDL-TG/LDL-TG ratio was, however, significantly higher in LF (p < 0.05) 
compared to diabetic rats. 
VliDL-apo-B/LDL-apo-B 
Diet and diabetes had no significant effects on VLDL-apo-B/LDL-apo-B 
ratio (Table 18). 
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SUMMARY OF RESULTS 
Food Intake Study 
IF-fed rats consumed more g diet/day than BT- and CO-fed rats. 
There was no difference when data were expressed as kcal consumed per 
day. 
Rat Body Weight 
Body weight of rats increased throughout the feeding periods. Rats 
fed the high-fat diets, however, appeared to gain more weight than 
animals fed the low-fat diet. 
Plasma Glucose and Insulin 
Plasma glucose 
Diets had little effect on fasting plasma glucose levels \^ich, 
however, were lower than those of diabetic rats. 
Plasma insulin 
As with the glucose data, diets had little effect on fasting plasma 
insulin levels which, however, tended to be lower in BT- than CO- and 
LF-fed rats. Insulin levels were lower in diabetic compared to all 
normal rats. 
76 
Lipoprotein-Protein 
Rats fed the high-fat diets over a four-month period had lower 
VLDL-bound protein than animals fed high-fat or low-fat diets for two 
months each. In VLDL, protein concentration was higher in diabetic rats 
than animals fed high-fat diets but not LF-fed rats. Thus, duration of 
high-fat feeding and diabetes affected VLDL-protein levels. Diet and 
streptozotocin-induced diabetes had no effect on protein levels in LDL 
and HDL. 
Lipoprotein-Phospholipids 
There was no dietary effect on phospholipid levels in any of the 
lipoprotein fractions. 
Lipoprotein-Cholesterol 
VLDL-cholesterol 
Experimental diets did not induce changes in TC, FC and CE levels. 
Generally, VLDL appeared to contain more CE than FC in rats fed the 
experimental diets. This was not true in diabetic rats where FC levels 
were higher than CE levels. An increase in TC in diabetic rats compared 
to animals fed experimental diets was due to a marked increase in FC and 
not CE levels. 
LDL-cholesterol 
In contrast to VLDL-cholesterol data, CE levels were always higher 
than FC levels in all animals, including diabetic rats. TC, FC and CE 
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levels were not affected by diets but were generally lower in diabetic 
compared to all normal rats. 
HDL-cholesterol 
In HDL, all animals exhibited higher CE than FC levels. Diet did 
not affect TC and CE levels in HDL. FC levels, however, were higher in 
CO- and LF- than BT-fed rats. The tendency for a decrease in TC levels 
in BT- compared to CO- and LF-fed rats was, therefore, due to a change 
in FC values. Diabetes resulted in a decrease in cholesterol levels 
compared to normal rats fed experimental diets. 
Lipoprotein-Triglycerides (TG) 
VLDL-triglyceride 
There was no significant dietary effect on VLDL-TG. VLDL-TG levels 
were higher in diabetic than all normal rats, 
LDL-triglyceride 
LDL-TG levels were distinctly lower in CO- and LF- than BT-fed rats. 
A dietary change from CO to BT (=NBT) resulted in a marked elevation of 
TG, with NBT similar to diabetic rats. High-saturated fat feeding, 
therefore, led to an increase in LDL-TG levels similar to a diabetic 
state. 
HDL-triglyceride 
In contrast to VLDL- and LDL-TG data, there was no dietary effect 
on HDL-TG levels which were, however, lower in diabetic compared to all 
other rats. 
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Lipoprotein-Apoproteins 
A major decrease in intensity of apo-E bands both in LDL and HDL 
was noticeable in polyacrylamide gels of diabetic rats compared to nor­
mal animals fed the experimental diets. 
VLDL-apoproteins 
Generally, diet and diabetes had little effect on apo-B levels. 
Percent of apo-B, however, appeared to be higher in BT, NBT and diabetic 
rats compared to all other animals. 
Apo-E levels were not different in BT, CO, LF and D rats. However, 
feeding high-fat diets for four months compared to two months resulted 
in an increase in apo-E levels. 
In contrast to apo-E data, feeding high-fat diets for four months 
compared to two months resulted in a decrease in apo-C levels. In 
general, apo-C levels were highest in LF-fed rats and lowest in diabetic 
rats and animals fed high-fat diets over a four-month period. 
LDL-apoproteins 
Apo-B levels were lower in LF-fed rats compared to animals fed high-
fat diets. Degree of saturation of dietary fat did not cause differences 
in apo-B levels. Diabetic rats had higher apo-B levels than all other 
animals. 
Apo-E levels were lower and sometimes undetectable in diabetic rats 
compared to animals fed experimental diets. In contrast to apo-B data, 
apo-E was higher in LF-fed rats compared to animals fed high-fat diets. 
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Similar to apo-B data, degree of saturation of dietary fat did not af­
fect apo-E levels in LDL. 
HDL-apoproteins 
Although present only in trace amounts, apo-B levels were higher 
in diabetic rats than in all normal animals. 
Apo-E levels were higher in LF-fed rats compared to animals fed 
high-fat diets. Apo-E levels were not affected by degree of saturation 
of dietary fat. Apo-E was almost undetectable in HDL of diabetic rats. 
Apo-AI levels were lower in LF compared to BT, CO, NBT and NCO rats. 
Diabetic rats had higher apo-AI levels than CO- and LF- but not BT-fed 
rats. 
There was no dietary effect on apo-C levels except in LF and NCO 
rats, with higher apo-C levels in LF than in NCO rats. Apo-C levels were 
higher in diabetic rats than all normal animals. 
Triglyceride Metabolism 
HDL-TC/VLDL-TG 
The ratio was not affected by amount and degree of saturation of 
dietary fat but tended to be larger in CO compared to BT- and LF-fed rats. 
Diabetes resulted in a decrease in the HDL-TC/VLDL-TG ratio, indicating 
a decrease in HDL-TC and/or increase in VLDL-TG levels in diabetic com­
pared to rats fed experimental diets. 
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VLDL-TG/LDL-TG 
The ratio was higher in LF-fed rats compared to animals fed high-fat 
diets and to diabetic rats. There was no difference in ratios between BT-
and co-fed rats. 
VliDL- apo- B /LDL- apo- B 
The ratio was not affected by diet and diabetes, indicating similar 
flux of apo-B from VLDL to LDL in all animals. 
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DISCUSSION 
Food Intake and Body Weight 
All rats appeared to adapt to a uniform calorie or energy intake. 
The three experimental diets were a high-saturated fat or high-beef tallow 
diet (BT), a high-polyunsaturated fat or high-corn oil diet (CO) and a 
high-carbohydrate or low-fat diet (IF). No cholesterol was added to any 
of the experimental diets. Rats fed LF diet consumed more food per day 
than rats fed either high-BT or high-CO diets. This was expected be­
cause the energy value of the LF diet was lower than that of BT or CO 
diets. Nevertheless, rats fed the high-fat diets gained more weight 
than animals fed the low-fat diet. This diet-related difference in ap­
parent efficiency in fat deposition was previously observed in mice 
(Hennig et al., 1980) and rats (Sclafani and Gorman, 1977). Dietary 
induced thermogenesis (Sharief and Macdonald, 1982) may have been partially 
responsible for the resistance to body weight increases in the rats fed 
the low-fat diet. 
Plasma Glucose and Insulin 
In the present study, the amount and degree of saturation of dietary 
fat had no significant effects on fasting plasma glucose levels. How­
ever, nonsignificance of plasma glucose differences after a 12-hour fast 
does not rule out a possible alteration of glucose tolerance by feeding 
diets high in saturated fat. 
Due to necrosis of the pancreatic P-cells, caused by i.v. injection 
of streptozotocin (Cooperstein and Watkins, 1981), plasma insulin levels 
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were lower in diabetic rats than in all other animals. This led to the 
marked elevation of plasma glucose in the diabetic rats. As with the 
glucose data, diet-induced changes in insulin levels were not signifi­
cant. Nevertheless, animals fed the high-BT diet tended to have lower 
plasma insulin levels than rats fed the high"CO or LF diets. Whether 
this was due to a decrease in synthesis or to a release of insulin from 
the pancreas needs to be determined. Streptozotocin-induced diabetes 
has been suggested to be due in part to a direct effect of streptozotocin 
on the islet cell membranes, thereby changing membrane properties (Cooper-
stein and Watkins, 1981). Rapid changes in membrane fatty acid composi­
tion controlled by degree of saturation of dietary fatty acids have 
been observed in inner membrane of cardiac mitochondria (Innis and 
Clandinin, 1981) and liver (Flick, 1981). One might then speculate 
that the tendency for lower plasma insulin levels in rats fed the high-
beef tallow diet was due in part to a change in the nature of P-cell 
membrane fatty acids. 
Lipoprotein-Cholesterol 
Dietary fat effects 
In the present study, the virtually cholesterol-free diets differing 
in amount and degree of saturation of dietary fat did not induce changes 
in total cholesterol, free cholesterol or cholesteryl ester levels, 
either in very low density lipoprotein (VLDL) or low density lipoprotein 
(LDL). Similar results were observed with male and female virgin rats 
(Dupont et al., 1972, 1978). Up to about 12 months of age, serum 
cholesterol levels were affected neither by age nor amount and degree of 
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saturation of dietary fat (Dupont et al., 1972). However, frmn about 
12 to 21 months, serum-cholesterol increased linearly with age, regard­
less of dietary fat composition (Dupont et al., 1978). It appears, there­
fore, that changes in total plasma-cholesterol levels which may occur 
during the lifetime of rats may be independent of amount and degree of 
saturation of dietary fat. 
As with LDL, cholesteryl ester levels in high density lipoprotein 
(HDL) were always higher in all animals than HDL-free cholesterol levels. 
In HDL, free cholesterol levels were higher in rats fed CO and LF diets 
than in BT-fed rats, suggesting the possibility of an increase in 
lecithin-cholesterol-acyl-transferase (LCAT) activity in BT-fed animals. 
Generally, cholesterol transferred to HDL from other lipoprotein frac­
tions is rapidly esterified by LCAT (Getz and Hay, 1979). A tendency 
for a decrease in total HDL-cholesterol levels in BT and NBT as compared 
to CO, NCO and LF rats was, therefore, due to a change in free cholesterol 
values. 
Diabetes effects 
In diabetic rats, VLDL-cholesterol levels were elevated compared to 
normal animals fed the experimental diets. This was due to a marked in­
crease in free cholesterol and not cholesteryl ester. Increased HMG-CoA 
reductase (rate limiting enzyme of cholesterol synthesis pathway) 
activity in the intestine of rats with streptozotocin-induced diabetes 
has been reported by Nakayama and Nakagawa (1977) and Saudek and Eder 
(1979). The increase in VLDL-cholesterol thus may be due to increased 
intestinal synthesis of chylomicron-choies terol. The liver takes up 
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chylomicron remnant-cholesterol, thereby making cholesterol available 
for incorporation into VLDL. 
LDL-cholesterol levels were generally lower in diabetic rats com­
pared to animals fed experimental diets. Van Toi (1977) also reported 
a decrease in LDL-cholesterol levels in the diabetic rat. However, in 
most human studies, elevated levels of LDL-cholesterol have been shown 
both in insulin-dependent (Lopes-Virella et al., 1981; Reckless et al., 
1978) and noninsulin-dependent patients (Taskinen and Nikkila, 1979). 
This species discrepancy could be due to a quantitatively different 
transport mechanism of cholesterol since human plasma contains 20-25 
times more LDL than rat plasma (Getz and Hay, 1979), 
Diabetes resulted in a decrease in HDL-cholesterol levels com­
pared to normal rats fed experimental diets. This was due both to a 
decrease in free cholesterol and cholesteryl ester, suggesting no dif­
ference in LCAT activity in diabetic compared to normal rats. The rat 
data are supported by human studies where LCAT activity was similar in 
diabetic patients and a control population (Prager et al., 1980). Salter 
et al. (1981) suggested that reduced levels of HDL-cholesterol (primarily 
HDL^-cholesterol) were secondary to hypertriglyceridemia. 
In humans, HDL-cholesterol levels have been shown to be positively 
correlated with lipoprotein lipase activity of adipose tissue (Nikkila 
et al., 1978). HDL-cholescerol concentration may then be dependent on 
the efficiency of the removal of triglyceride-rich lipoproteins from the 
circulation since insulin therapy has been shown to increase lipoprotein 
lipase activity in humans (Taskinen and Nikkila, 1979). 
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Lipoprotein-Triglycerides 
Dietary fat effects 
Amount and degree of saturation of dietary fat had no effect on 
VLDL-triglyceride levels. Because the fractional catabolic rate (FCR) 
of VLDL-apo-B is about 0.2 per hour (FCR is the fraction of total plasma 
pool of VLDL-apo-B catabolized per hour) (Huff et al., 1981), nonsignifi-
cance of VLDL-triglyceride difference after a 12-hour fast does not rule 
out shorter-term changes in VLDL synthesis or degradation due to high-
saturated fat feeding. 
The most pronounced effect of feeding high-saturated fat was on LDL-
triglyceride levels which were significantly higher in rats fed the high-
BT diet compared to rats fed the high-CO or -LF diets. Since LDL-protein 
levels were not affected by diets, the hypertriglyceridemia which resulted 
from saturated fat feeding was probably due to larger lipoprotein particles 
that transported more lipid, especially triglycerides. 
The excess triglyceride in LDL could be due to a metabolic defect 
in the progressive delipidation of VLDL and chylomicrons. In addition 
to hormonal control of lipoprotein lipase via insulin concentrations 
(Taskinen and Nikkila, 1979), it is conceivable that at very elevated 
triglyceride-rich lipoprotein levels, lipoprotein lipase becomes saturated 
resulting in diminished activity. This could lead to a less efficient 
delipidation of VLDL and chylomicrons with an accumulation of inter­
mediate density lipoproteins (IDL) and chylomicron remnants of similar 
density as the LDL fraction (Kris-Etherton and Cooper, 1980). This 
phenomenon would explain in part the elevated triglyceride levels in 
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diabetic rats and animals fed high-BT diet. 
Â decrease in catabolism of LDL molecules also could have contributed 
to the excess LDL-triglyceride levels in BT-fed animals. However, the 
extent and nature of a possible defect in LDL removal in rats fed high-
BT diet is not clear since both LDL-protein and LDL-cholesterol levels 
were not affected significantly by dietary treatment. 
In contrast to LDL-triglyceride data, there was no dietary ef­
fect on HDL-triglyceride levels. Similar results were observed in 
humans (Fisher et al., 1981) who also received high-fat diets which were 
chole sterol-free. 
Diabetes effects 
VLDL-triglyceride levels were significantly higher in diabetic 
rats than normal animals fed experimental diets. This was probably due 
to an increased number of circulating VLDL particles since both VLDL-
protein and VLDL-cholesterol levels were also elevated in diabetic rats. 
Theoretically, the rise in plasma-triglyceride levels could result from 
increased lipoprotein production or decreased removal of circulating 
lipoproteins, or from a combination of both factors. Mancini et al. 
(1980) suggested that enhanced lipolysis in adipose tissue of diabetics 
contributes to hypertriglyceridemia by providing increased amounts of 
precursors (fatty acids) for triglyceride synthesis in the liver. Im­
paired extrahepatic lipoprotein lipase in untreated diabetes (Brunzell 
et al., 1979) might also be partially responsible for diabetic hyper­
triglyceridemia, because ^H-palmitate labeled VLDL was removed more 
slowly from the circulation in diabetic rats than in normal rats 
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(van Toi, 1977). 
A dietary change from high-CO to high-BT diets resulted in a marked 
elevation of LDL-triglycerides. This increased level of LDL-triglycerides 
was also seen in streptozotocin-induced diabetic rats. However, plasma-
triglyceride levels have been reported to be related to the degree of 
diabetes and, therefore, to the amount of streptozotocin injected (Chen 
et al., 1979). Nevertheless, the resemblance of LDL-triglyceride levels 
in animals fed the high-BT diet to those in diabetic rats suggests that 
a long-term intake of diets high in saturated fats or low in polyun­
saturated fats could contribute to a plasma lipid profile analogous to 
that of diabetes. Elevated LDL-triglyceride levels observed in diabetic 
patients (Schonfeld et al., 1974) have been correlated with a relative 
increase in IDL or remnant particle accumulation (Mancini et al., 1980). 
HDL-triglyceride levels were lower in diabetic rats than in normal 
animals. Smaller sized circulating HDL particles appeared to be 
responsible for the decreased HDL-triglyceride levels in the diabetic 
rats since HDL-cholesterol but not HDL-protein levels were lower in 
diabetic rats than in normal animals. 
Apoproteins 
Apo-B 
VLDL-apo-B tended to be higher in high-BT-fed and diabetic rats 
than in rats fed high-CO or LP diets. This suggested a possible in­
crease in synthesis of VLDL in BT and diabetic rats since apo-B is neces­
sary for formation and secretion of triglyceride-rich particles (Getz 
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and Hay, 1979). LDL-apo-B levels were lower in LP-fed rats compared to 
animals fed high-fat diets. Diabetic rats also had higher LDIr*apo-B 
levels than all other animals which agrees with reports in the litera­
ture of elevated plasma-apo-B levels in insulin-dependent (Alaupovic, 
1980) and noninsulin-dependent diabetic humans (Schonfeld et al., 1974). 
There exists a direct precursor-product relationship between apo-B 
in VLDL and LDL (Eisenberg and Rachmilewitz, 1975; Getz and Hay, 1979), 
and a positive correlation (r = 0.35; p = 0.01) between VLDL-apo-B and 
LDL-apo-B levels supports the findings that apo-B remains associated with 
the VLDL-IDL-IiDL delipidation cascade (Brewer, Jr., 1981). The removal 
of apo-B from the circulation is thought to occur primarily in the form 
of LDL particles (Schaefer et al.,1978b). Therefore, an elevation of 
LDL-apo-B in diabetic compared to normal rats was probably associated 
with a slower catabolic rate of LDL particles in diabetic animals. 
Apo-E 
VLDL-apo-E levels were not different in BT, CO, LF and diabetic 
rats. Degree of saturation of dietary fat did not affect apo-E levels 
in VLDL, LDL and HDL. Thus, the marked increase in LDL-triglyceride 
levels in BT and diabetic rats cannot be explained by possible inhibitory 
(Ekman and Nilsson-Ehle, 1975; Ganesan et al., 1976) or activating 
(Yamada and Mirase, 1980) effects of apo-E on lipoprotein lipase. 
Both in LDL and HDL, apo-E levels were higher in LF-fed rats com­
pared to animals fed high-fat diets, suggesting a net mass transfer of 
apo-E from VLDL to HDL during lipolytic breakdown of VLDL in LF-fed rats 
(Alaupovic, 1981). Apo-E levels were much lower in LDL of diabetic rats 
89 
compared to normal animals and almost not detectable in HDL of diabetic 
rats. Similar results were observed by Bar-On et al. (1976b) and Deutsch 
et al. (1980). The lack of apo-E in LDL and HDL of diabetic rats could 
have been partially due to a decrease in apo-E synthesis since apo-E 
generally appears to enter the circulation from the liver with HDL 
particles (Schaefer et al., 1978b). 
Apo-C 
In VLDL, apo-C or low molecular weight proteins appeared to be 
higher in normal rats fed experimental diets for two months compared to 
diabetic rats. However, a decrease in VLDL-apo-C to levels similar to 
those seen in diabetic rats was observed in animals fed the high-fat 
diets for four months. These findings suggest that the duration of high-
fat feeding had a more pronounced effect on VLDL-apo-C levels than the 
degree of saturation of dietary fat. In HDL, apo-C levels were signifi­
cantly higher in diabetic rats than in normal animals. Alaupovic (1981) 
suggested that the rate of release of apo-C-containing lipoprotein 
particles from VLDL to HDL during lipolysis reflected the state of tri­
glyceride metabolism. Judging from the apo-C data alone, the lipolytic 
rate would have been greater in the diabetic rats than in the normal 
animals. This, however, does not explain the fact that triglyceride 
levels were generally higher in VLDL and LDL and lower in BDL in diabetic 
rats than in normal animals fed experimental diets. Comparing lipolytic 
rate with the status of apo-C metabolism must be done with caution 
since the C apoproteins, CI, CII and CIII, have similar molecular weights 
but different functions related to lipid metabolism. Apo-CII is essential 
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for lipoprotein lipase activity (Nilsson-Ehle et al., 1980), whereas 
apo-CIII has been shown to inhibit the activation of lipoprotein lipase 
(Ganesan et al., 1976; Saudek and Eder, 1979). In addition, apo-C 
can exchange between lipoprotein particles and might not be a suitable 
marker for the metabolism of particular lipoproteins (Brewer, Jr., 1981). 
Apo-A 
In man, apo-AI and apo-AII are the major apoproteins of HDL (Schaefer 
et al., 1978b), However, apo-AII is only a minor component of rat HDL 
(Swaney et al., 1977). In this study, therefore, apo-A represents only 
apo-AI. 
Amount but not degree of saturation of dietary fat had an effect on 
apo-Al levels in this study. Similar results were observed in humans 
(Illingworth et al., 1981). Apo-AI was significantly lower in LF-fed 
rats compared to animals fed the high-fat diets and diabetic rats. 
Apo-Al levels were significantly higher in diabetic rats than CO- and 
LF-fed but not BT-fed rats. These findings could reflect an increased 
LCAT activity in diabetic rats and normal animals fed high-BT diet since 
apo-AI is the major activator of LCAT (Getz and Hay, 1979). Tuvemo et al, 
(1981) reported significantly higher levels of apo-AI in diabetic children 
than in normal children. The increase in apo-A during a diabetic state 
could be partially due to lack of insulin in untreated diabetes. Weidman 
et al. (1982) reported a decrease in apo-AI levels upon insulin treatment 
in human diabetic ketoacidosis, with the largest decrease in apo-AI 
levels in the more hypertriglyceridemic subjects. Apo-AI status may 
reflect degree of control of diabetes. 
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Dietary Saturated Fat and Diabetes 
Since apo-B remains associated with the VLDL-IDL-LDL delipidation 
cascade (Brewer, Jr., 1981)> the ratios VLDL-TG/LDL-TG and VLDL-apo-B/ 
LDL-apo-B could be indicators of lipolytic activity. The ratios were 
not significantly different between BT- and CO-fed rats and between rats 
fed the high-fat diets and diabetic animals, suggesting no metabolic im­
pairment in lipolytic activity. However, in addition to hormonal control 
via insulin concentration (Taskinen and Nikkila, 1979), lipoprotein 
lipase (LPL) may become saturated at very high concentrations of 
triglyceride-rich lipoproteins (Nilsson-Ehle et al., 1980), which would 
explain in part elevated triglyceride levels in VLDL and LDL. To what 
extent increased triglyceride levels in LDL of BT-fed rats were due to 
a possible defect in LDL removal or to an accumulation of IDL or remnant 
particles (Mancini et al., 1980) is not clear. Compared to the high-BT 
diet, diabetes appeared to have a more pronounced effect on plasma 
triglyceride metabolism, with more significant metabolic changes. 
Hypertriglyceridemia was associated with LDL in normal BT-fed rats 
and both with VLDL and LDL in diabetic animals. Although LDL usually 
carries less triglycerides than VLDL, triglyceride concentration in LDL 
during a fasting state may reflect effects of dietary fat composition on 
total plasma triglyceride metabolism, because the normal FCR of LDL is 
0.3 to 0.8 per day (Hopkins and Williams, 1981). 
The decreased HDL-cholesterol levels in diabetic rats when compared 
to normal rats and the tendency for a decrease in total HDL-cholesterol 
levels due to a significant decrease in free HDL-cholesterol in BT-fed 
ccnapared to CO- and LF-fed rats, also might have been partly due to a 
delay in chylomicron clearance (Grundy and Mok, 1976). HDL-cholesterol 
levels have been reported to be inversely correlated with plasma or VLDL-
triglyceride levels, both in normolipidemic and hyperlipoproteinemic 
subjects (Schaefer et al., 1978a). Comparing the two high-fat diets, BT 
feeding tended (p < 0.2) to result in a smaller HDL-TC/VLDL-TG ratio 
than CO feeding. The ratio was significantly lower in diabetic rats 
compared to all normal animals, indicating both a decrease in HDL-total 
cholesterol and increase in VLDL-triglyceride levels in diabetic rats. 
Apo-AI levels, which were significantly higher in diabetic rats than 
in CO- and LF- but not in BT-fed animals, also support a metabolic rela­
tionship between high-saturated fat feeding and diabetes. Since insulin 
treatment led to a decrease in apo-AI in human diabetic ketoacidosis 
(Weidman et al., 1982), low insulin levels in diabetic and normal BT-fed 
rats could have been responsible in part for the elevated apo-AI levels. 
Apo-C and apo-E but not apo-A and apo-B can exchange between VLDL 
and HDL (Alaupovic, 1981). which would explain why there appeared to be 
no comparative relationship between apo-C and apo-E levels and lipoprotein 
lipids among normal animals fed experimental diets and diabetic rats. 
The results related to lipoprotein composition support the hypothesis 
that excess intake of a diet too high in saturated fat (or too low in 
polyunsaturated fat) over a long period of time could contribute to a 
metabolic pattern resembling that of a diabetic state. In addition, the 
hyperlipidemia observed in diabetic rats and animals fed the high-BT diet 
appeared to be primarily due to a defect in triglyceride metabolism and 
not cholesterol metabolism. 
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CONCLUSION AND SUGGESTIONS FOR FURTHER STUDIES 
A relationship with regard to plasma lipoprotein lipid and protein 
metabolism has been shown between high-saturated fat feeding and diabetes. 
Excess intake of a diet too high in saturated fat or too low in poly­
unsaturated fat may contribute to a metabolic pattern which resembles 
that of a diabetic state. 
However, many questions remain unanswered and further research is 
needed to clarify some of the results. It is not really clear whether or 
not feeding the high-beef tallow and not the high-corn oil diet results 
in an increase in VLDL-triglyceride levels under nonfasting conditions. 
Elevated triglyceride-rich lipoprotein levels, which include chylomicrons 
and VLDL, could be due in part to an increase in synthesis at the in­
testinal level or in the liver. One might feed radioactively labeled 
triglycerides or perfuse livers with labeled fatty acids to explore 
dietary effects on lipoprotein synthesis. 
Whether high-saturated fat diets can inhibit lipoprotein lipase 
activity directly or indirectly via affecting synthesis or availability 
of apo-CII is not known. Subclasses of apo-C (apo-CI, apo-CII and apo-
CIII) could be separated and quantitated by isoelectric focusing gel 
electrophoresis. This technique would, however, eliminate the opportunity 
to quantitate all other apoproteins at the same time. 
The most pronounced effect of feeding highrsaturated fat was on 
LDL-triglyceride levels. A diminished removal of LDL from the circula­
tion or the accumulation of IDL or remnant particles in the LDL density 
fraction (d = 1.006 to 1.063 g/ml) due to high-saturated fat feeding 
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cannot be ruled out. Since apo-B remains associated with the VLDL-IDL-
LDL delipidation cascade (Brewer, Jr., 1981), one could analyze for 
radioactively labeled apo-B and compare relative concentrations in lipo­
protein fractions and hepatic and extrahepatic tissues. 
It also needs to be explored why plasma insulin tended to decrease 
in animals fed the high-beef tallow diet. Can different compositions of 
dietary fat lead to a change in the fatty acid composition of the 
pancreatic islet cell membranes? This would conceivably have an effect 
on insulin release. It is also not known whether synthesis of insulin 
can be altered by degree of saturation of dietary fat. Plasma insulin 
levels in relation to glucose tolerance may further define a relation­
ship between saturated fat feeding and diabetes. 
The breeder rats in the present study were probably too young to 
respond more obviously to changes in dietary fat composition. Thus, 
older breeder rats with a genetic tendency for obesity and diabetes 
should be used for further studies. Although larger animals (for 
example, pigs (Reitman et al.. 1982)) might be a better model to 
study lipoprotein metabolism, high costs due to care and maintenance 
often prohibit their use. 
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